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1. INTRODUCTION
1.1. ANALYSIS OF PROTEIN-DNA INTERACTIONS
The study of the interaction of proteins, whether they are enzymes, regulatory
proteins or structural proteins, with nucleic acids is one of the most exciting areas
of modern molecular biology. Structural studies of DNA-binding proteins and their
complexes with DNA have proceeded at an accelerated pace over the last two
decades due to important technical advances in molecular genetics, DNA synthesis,
UV-catalyzedcrosslinking,proteincrystallography,andnuclearmagnetic
resonance spectroscopy. The classical direct methods used to investigate protein-
DNA interactions are X-ray diffraction and NMR spectroscopy, but both these
methods have certain limitations. A critical prerequisite of the crystallography
method is the preparation of a well-ordered crystalline nucleoprotein complex that
provides X-ray diffraction data of sufficient resolution. Few of the many protein-
DNA systems investigated produce high quality X-ray crystals. In addition, the
nonphysiological conditions often required to produce X-ray quality crystals
diminish the biological relevance of the study. Even with these severe limitations,2
X-ray crystallography is still the most powerful tool used to visualize protein-DNA
interactionsattheatomiclevel.Multidimensionalhighresolution NMR
spectroscopy was developed in the last decade and used to provide information
about thekinetic and thermodynamic properties of protein-DNA systems.
However, the complexity of the NMR spectra limits this method to proteins with a
molecular weight below 40 kDa.
The emergence of mass spectrometry as an analytical tool in biochemical research
has opened up new possibilities for investigating protein-DNA interactions. It has
been shown that intact nucleoprotein complexes can be analyzed by MALDI [1]
and electro spray mass spectrometry [2].
A new direct method for studying protein-DNA complexes combining low
intensity UV crosslinking with mass spectrometry was introduced by Barofsky et a!
in 1994 [3]. Soon after, laser-induced crosslinking [4,5] and chemical crosslinking
[6] were used in combination with mass spectrometry to investigate protein-DNA
interactions. This method had become increasingly popular in recent years [7-14].3
1.2. UV CROSSLINKING
Early in the 1960s Smith [15] and Alexander and Moroson [16] published
experimentalresultsindicatingthat absorption of UV light could induce
crosslinking of proteins to DNA in living cells. Over the next 40 years, UV
photochemical crosslinking became a well-established biochemical procedure used
for determining the contact domains between nucleic acids and proteins in
nucleoprotein complexes [17-19]. According to this procedure, UV light (in the
range of 250-270 nm), can be used to induce "zero-length" covalent bonds between
DNA nucleobases and certain amino acids from the protein situated in close contact
with the DNA. Upon UV irradiation, DNA bases can absorb photons and produce
excited state radicals with lifetimes on the order of a few picoseconds to a few
microseconds. Because the time scale for the motion of the nucleoprotein complex
is on the order of milliseconds, these reactive radicals have the opportunity to form
covalent bonds with certain amino acids that are in contact with the DNA, thereby
"freezing" the interaction between the biopolymers. The crosslinked complexes can
then be isolated for further characterization.
Any nucleotide present in DNA could in principle be involved in photoreactions,
but the reactivity of different nucleotides varies greatly. Thymine appears by far to
be the most reactive nucleobase and for this reason deoxythymidines are used
frequently as DNA substrates in UV crosslinking experiments.ru
Several side reactions normally occur during the UV crosslinking process. These
side reactions include protein denaturation, dimerization or degradation, as well as
DNA modification or degradation. Crosslinking yields are relatively low and
usually less than 10% of a given protein is crosslinked. Higher crosslinking yields
due to minimized side reactions can be obtained if UV lasers are used instead of
low intensity UV lamps.
Crosslinked nucleoprotein complexes are usually analyzed first by denaturing
polyacrylamide gel electrophoresis (PAGE). The crosslinked protein migrates
slower than the free protein and produces a shifted gel band. For this reason, the
technique employed to detect crosslinked complexes is called electrophoretic
mobility shift assay. Several small-scale electrophoretic mobility shift assays have
to be conducted in order to optimize the irradiation time and the ratio of
oligonucleotide to protein to form a stable protein-DNA complex.
1.3. MATRTX-ASSISTEDLASERDESORPTION-IONIZATIONMASS
SPECTROMETRY
Since the first description of matrix-assisted laser desorption-ionization (MALDI)
mass spectrometry by Karas and Hillenkamp [20,2 1], MALDI MS has become a
widespread analytical technique for the analysis of peptides,proteins and
oligonucleotides. The design of the MALDI-TOF instrument is illustrated in Figure
1.1. The principal components include a pulsed UV laser, a beam attenuator,a sample plate, the vacuum system, extraction lenses, the flight tube, the ion
detector, and the data analysis system.
In the MALDI experiment, analyte molecules are diluted in a matrix solution (to
about 1:5000 molar ratio) and spotted on the sample plate. After the solvent is
evaporated and sample crystallization has occured, the plate is transferred to the
vacuum system of the mass spectrometer. The function of the matrix is to isolate
the sample molecules from each other and to absorb photons from the pulsed UV
laser. Absorption of the laser energy causes rapid desorption of the matrix
molecules into the gas phase carrying the analyte molecules with them. Ionization
is thought to occur primarily via protonation in the plume above the sample plate
[112]. These protonated molecules ([M +Hf)are analyzed by a time-of-flight
(TOF) mass spectrometer, because this mass analyzer is well-suited to the pulsed
nature of laser desorption. All ions are accelerated to a uniform energy (20-30 keV)
and then allowed to fly in a field-free flight tube to reach the detector. The total
flight-time is measured from the time of the laser pulse until the ions reach the
detector and generate a signal. This time-scale is converted into a mass scale in
order to obtain a mass spectrum. As seen from the formula from Figure 1.1, the
flight time of each ion species is directly related to its mass to charge ratio (m/z). In
practice, instead of using this formula, the mass scale is calibrated by using well-
defined molecular weight standards.
The TOF analyzer is highly efficient because all ions of different m/z ratios arising
from a single laser shot are measured; they simply arrive at the ion detector at7
differenttimes.Performancespecificationsofcommercial MALDI-TOF
instruments include a resolving power of 500 (in the linear mode), a mass
determination accuracy of about 100 ppm, a sensitivity of better than 1 pmol, a
mass range of 500-300,000 Da and a spectrum acquisition time of 1 mm. The poor
resolving power of the MALDI-TOF instrument in the linear mode isa
consequence of the initial temporal distribution and initial velocity distribution of
the generated ions. The temporal distribution of ions (observed for ions formed at
different times) can be significantly reduced by forming the ions with a short laser
pulse (1-10 ns) on a flat surface (MALDI sample plate) and using fast, high-
performance electronic devices for data recording. The initial velocity distribution
of ions will cause the ions with the same m/z ratio to have different flight times.
The resolution of MALDI spectra was significantly improved in 1995 [22,23] by
the application of a time-delayed ion extraction technique originally introduced in
1953 [113]. A short delay (20-200 ns) is introduced between the laser pulse and the
application of the extraction voltage so that the ions from the source can drift apart
by virtue of their initial velocity differences. Initially faster ions penetrate deeper
into the source volume than initially slower ions of the same mass. When the
extraction voltage is applied after the delay time, the faster ions, which are now
closer to the extraction grid, experience a lower extraction potential than the slower
ions. Consequently, the initially slower ions acquire more kinetic energy during the
extraction/acceleration step than the initially faster ions. By adjusting the delay
time and/or the extraction potentials one can arrange for the initially slower ions to8
catch up with the initially faster ions of the same mass exactly at the detector plane
(space-focus plane) in order to obtain maximum instrumental resolution.
The resolution of the instrument can be improved further by using an electrostatic
ion mirror (reflectron) for focusing ions with an initial kinetic energy distribution
[24]. The ion mirror is placed at the end of the field-free region and creates a
retarding electric field, causing ions to slow down and reverse direction. Ions of a
given mass with higher kinetic energy penetrate deeper into the mirror before they
turn around, and have a longer flight-path through the reflector than ions of the
same mass with a lower kinetic energy. Thus, a higher kinetic energy is
compensated for by a longer flight-path. By using delayed extractionin
combination with an ion mirror, the resolving power of a MALDI-TOF instrument
can be increased to greater than 20,000 over a fairly broad mass range (500-5,000
Da). The MALDI spectra presented in this thesis were recorded on a home-build
instrument, equipped with delayed extraction and an ion mirror [1].
MALDI-MS is a routine technique used for protein identification by peptide
mapping. MALDI-TOF peptide mapping operates efficiently when a significant
number of peptide peaks can be measured, but until quite recently it possessed
almost no power to characterize, i.e. sequence, an individual peptide whose signal
appeared in the spectrum. Characterization of individual peptide ions in MALDI-
TOF instruments has been possible for some time with the postsource decay (PSD)
technique [25]. However, the low yield of fragment ions significantly reduces the
utility of PSD analysis in all but a few cases. The possibility to interrogate thesequence of any peptide peak observed in a MALDI peptide map by tandem mass
spectrometry was demonstrated almost at the same time on a quadrupole-time of.
flight (QTOF) [26], ion trap instruments [27,28] and on a MALDI TOF/TOF
tandem mass spectrometer [29]. The later instrument, which uses high-energy (> 1
keV) collision induced disociation (CID) to fragment peptide ions, was made
possible by ion optics invented at Oregon State University and Uppsala (Sweden)
University [115].
1.4. ELECTROSPRAY IONIZATION MASS SPECTROMETRY
Electrosprayionization(ESI)coupledwith massspectrometry wasfirst
demonstrated in the early 1980s by Fenn et al. for small molecules [30] and in the
late 1980s for proteins [31]. In the most general sense, electrospray is a method of
generating a very fine liquid aerosol through electrostatic charging. In the case of
biomolecules, electrospray ionization provides a way to produce ions in the gas
phase, at atmospheric pressure, directly from solution. These ions can be analyzed
by a mass spectrometer. The essentials of an electrospray mass spectrometer are
shown in Figure 1.2. The analyte is dissolved in solution and pumped througha
metallic needle at flow rates between 5 and 10 tL/min. A high voltage power
supply is connected to the electrospray needle placed in front of the instrument.
When the high voltage (1-5 kV) is turned on, the liquid being pumped through the10
needle is transformed into a fine continuous mist of droplets that fly rapidly toward
the mass spectrometer's counter-electrode commonly held at ground potential.
Inlet
Figure 1.2. Design of the electrospray ionization source. The main components
are the pump, the electrospray needle and the high voltage supply.
The liquid charges up as it exits the needle and assumes a conical shape, referred to
as the "Taylor" cone [32]. At the tip of the cone, the liquid changes its shape into a
fine jet of liquid. Then, at some point in front of the instrument, the liquid jet
becomes unstable and breaks up into a mist of tiny droplets (less than 10 tm in
diameter) that are highly charged and repel each other very strongly. For this
reason, the droplets fly apart from each other and cover a wide surface area. As
solvent molecules evaporate, the droplets will shrink rapidly decreasing the
distance between the electrical charges on the droplet. When the electrostatic
repulsion between electrical charges overcomes the surface tension, the droplet11
blows apart into smaller droplets. This phenomenon, which is known as a Coulomb
explosion, is responsible for producing smaller and smaller droplets. Repetitive
Coulomb explosions can produce, according to some authors [3 3,34], nanometer
size droplets containing only one biomolecule. According to this model, the solvent
molecules will totally evaporate, leaving the macromolecules as gas phase ions.
Fenn et al. proposed a different ionization model [35,36]. They suggested that a
charged part of a biomolecule penetrates the surface of a small, highly charged
droplet produced by Coulomb explosions from an initially larger droplet. The
electrostatic repulsion between this part of the biomolecule and the droplet surface
would pull the entire biomolecule out of the droplet and would generate a gas phase
molecular ion. The essential difference between these two ionization models is that
in Fenn's model, the macromolecule plays an active role in the ionization process,
while in the first model the ionization process is passive (does not depend on the
analyte). Scientists are still debating over which of these models prevails.
Since the total charge has to be conserved, the electrospray process should also
involve an electrochemical conversion of ions to electrons. This conversion occurs
at the liquid-metal interface of the capillary through oxidation reactions. The
electrospray process can be viewed as an electrolytic cell in which the ion transport
does not occurs through uninterrupted solution, but rater as charged droplets and
later as ions in the gas phase [37]. In 1995 Van Berkel and Zhou proved that the
electrospray ion source behaves like a controlled-current electrolytic cell [38].12
A theoretical model for the electrostatic dispersion of liquid in electrospray, was
developed and verified experimentally by Wilm and Mann in 1994 [39]. According
to this model, the threshold voltage(UT)required to obtain a stable electrospray
depends on the distance from the liquid jet to the counter-electrode (d), the surface
tension of the liquid (y) and the dielectric constant of the medium(Eo):
0.5 UT=O.863 (ydIo) (1.1.)
The same authors demonstrate the following formula (1.2.), which relates the liquid
flow rate (F) to the emission radius (r) of the droplets emitted at the tip of the
Taylor cone:
1/3
r=(
2 2
2/3
F (1.2.)
y tan(7c12O)[(Ua/UT) 11111
where:
p - is the density of the liquid expressed inglcm3;
0is the liquid cone angle;
Uais the applied voltage.13
Formula (1.2.) predicts a higher desorption efficiency at lower flow rates because
the solvent evaporation is more efficient if the first generation of droplets formed
from the liquid jet are smaller. This would produce a higher ionization efficiency
and ultimately a higher sensitivity in electrospray mass spectrometry. The overall
efficiency, defined as the number of analyte ions recorded at the detector divided
by the number of molecules analyzed, is on the order of 1 0with conventional
electro spray sources coupled to quadrupole mass analyzers [40]. This overall
efficiency takes into account the desorption efficiency, the ionization efficiency and
the transfer efficiency into the vacuum system of the mass spectrometer.
Theoretically, the overall efficiency should be improved considerably at lower flow
rates. To verify experimentally these predictions, Wilm and Mann introduced the
nanoelectrospray (nanospray) source [3 9,40] designed to work at very low flow
rates (25 nL/min). They obtained an overall efficiency of 5 x i0with the nano-
ESI source, but the nanospray technique failed to become a routine technique for
most of the analytical labs performing protein analysis. The coupling of nanoscale
liquid chromatography with low flow (0.20.5 tL/min) microelectrospray mass
spectrometry turned out to be a better choice. An explanation from the last
statement will be given in the following section (1.4.).
Electrospray ionization has been coupled to all known mass analyzers (magnetic
sectors, quadrupoles, time-of-flight, Fourier transform ion cyclotron resonance
(FTICR) and ion traps [41]. Tandem mass spectrometers like triple-quadrupoles
[42] and QTOF5 (quadrupole/time-of-flight) [43] have became the most popular14
electrospray instruments used for protein identification and proteomics research.
Both instruments can be used to isolate peptide ions produced by electrospray and
fragment them under low energy (< 100 eV) CID conditions in order to obtain
sequencing information. Recently, a new dissociation method called electron-
capture dissociation (ECD) was interfaced to electrospray ionization on an FTICR
instrument [44] and shown to produce near complete MS sequence coverage for
peptides and small proteins.
The electrospray mass spectrum of a protein indicates the presence of a family of
charged states, averaging roughly one positive charge per 1,000 Da [45]. The
signals produced by all charged states between +20 and +30 of a 30 kDa protein,
would appear in the mass spectrum between m/z 1000 and m/z 1500. Each member
of the series of charge states for a particular protein is related to its nearest neighbor
by having one more or one less proton. The molecular weight of the parent
molecule can be determined from any two consecutive charge states [46].
The electrospray spectra presented in this thesis were recorded on an LC-Q ion trap
mass spectrometer (Thermo Finnigan, San Jose, CA) and on an API III triple-
quadrupole instrument (PE Sciex, Ontario, Canada).15
1.5. NANOSCALE LIQUID CHROMATOGRAPHY MASS SPECTROMETRY
The development of highly sensitive matrix-assisted laser desorptionlionization
(MALDI) and electrospray ionization (ESI) mass spectrometric techniques for the
analysis of peptides, proteins, and other biomolecules during the last decade
generated the concomitant development of miniaturized separation techniques.
Since electrospray is a continuous ionization technique, it can be more easily
coupled on-line to liquid chromatography. Although the initial interest in nanoscale
separations arose because of their increased separation efficiencies in comparison
with the analytical columns, the major driving forces behind this coupling were the
higher mass sensitivity that can be achieved for a given amount of sample and the
limited amount of sample available for analysis.
Packed fused-silica capillary column with less that 100 pm i.d. were introduced by
McGuffin and Novotny in early eighties [47] and the direct coupling with ESIIMS
was first demonstrated by Hunt et al in 1993 [48]. The term nanoscale liquid
chromatography (nano-LC), used for describing separations performed at flow rates
in the range of 10-1000 nL/min, was introduced by Moseley et al [49]. Later on,
Chervetpresentedtheinstrumentalrequirementsfornanoscaleliquid
chromatography [50].
In nano-LC, like in other microcolumn LC techniques, all chromatographic
volumes must be down-scaled by a factor (J:16
(1.3.)
where and j.d.nanoare the internal diameters of the conventional (analytical)
and nano-LC columns, respectively. This down-scaling is inevitable in order to
maintain the chromatographic performance of the nano-LC system. Down-scaling
from a 4.6 mm i.d. analytical colunm to a 75 pm i.d. nanocolunm, requires a factor
of about 4000. This factor applies to all components and parameters of the LC
system, such as flow rates, injection and detection volumes, and connecting
capillaries. Nanoscale liquid chromatography is performed using the following
parameters: flow rates between 0.2 and 0.4 j.tl/min, injection and detector volumes
of 5-10 nL, peak volumes of 50-100 nL and connection tubing volumes below 15
nL. The injection volume can be increased substantially in order to obtain adequate
sensitivity if sample focusing techniques are used for gradient separations. Dead
volumes associated with the coupling of the electrospray needle to the nanocolunm
can be eliminated if a fused-silica column with an integral frit - "PicoFrit" is packed
with the stationary phase. The column is connected to an injector placed in a plastic
box and the spraying voltage is applied at the injector after the sample is injected.
The direct coupling (with no make-up flow) of nano-LC with ESI-MS turned out to
be a highly sensitivite technique for peptide analysis. One reason for the high
sensitivity of nano-LC/ESI-MS in comparison with conventional micro-LC/ESI-17
MS is that electrospray ionization produces gas phase ions more efficiently at lower
flow rates (formula (1.2.)). More importantly, nanoscale separations produce very
narrow and very concentrated analyte bands, with peak volumes on the order of 50-
100 nL. ESI-MS behaves like a concentration-sensitive detector, and for this
reason, one can achieve sensitivities in the fmole/pL range for peptide analysis.
Nanospray is not as sensitive as nano-LC/ESI-MS because the level of the chemical
noise from the sample lowers the signal/background ratio in the MS spectrum. In
addition, because of the competitive nature of the electrospray ionization, not all
peptides present in the sample will produce a signal above the background level.
Nano-LC/ESI-MS became the preferred electrospray technique for peptide analysis
because it is more sensitive and more reliable than nano-ESI/MS and has the
potential to become a high-throughput analysis technique.
One of the limitations of nanoscale liquid chromatography coupled to electrospray
tandem mass spectrometry (nano-LC/ESI-MS/MS) is generated by the narrowness
of the chromatographic peak. The elution profile of a peptide peak is in the range of
7-15 s and frequently coeluting peptides are presented to the mass spectrometer
simultaneously. The instrument makes instant decisions as to which peptide ion to
select for the MS/MS event, and because peptide separation is a dynamic process,
some of the peptide ions (usually those with lower intensity) will not be selected
for fragmentation. For example, an ion trap mass spectrometer is able to record
about 30 MS/MS peptide spectra/mm. To overcome this problem, Davis and Lee
[51] introduced the concept of variable flow nanoscale separation in which peptides18
are separated at 200 nL/min, but the MS/MS spectra are recorded at a "peak
parking" flow rate of 25 nL/min.
In order to exploit the advantages of nano-LC, itis necessary to have a
micropumping system that can provide gradient elution at flow rates below 1
pL!min while maintaining accurate proportioning, homogeneous mixing with
minimal delay, and reproducible delivery of the mobile phase. The first nanoscale
LC systems commercially available were UltiMate (LC Packings, San Francisco,
CA) and Agilent 1100 (Agilent Technologies, Palo Alto, CA) introduced in early
2000. The most con-rn-ion way to achieve gradient elution in the nano-LC domain is
to insert a flow-splitter between a conventional HPLC solvent delivery system and
a nanocolumn. The inlet ports of most microinjectors designed for capillary LC
applications operating at flow rates of 5-10 tL/min have dead volumes between 5-
15 p.L. In nano-LC applications, dead volumes of this magnitude act as mixing
chambers that introduce delays in establishing the gradient and alter the delivery
system's gradient profile through solvent-mixing. Rather than taking inordinate
measures to minimize the unavoidable dead volumes between the splitting point
and the microinjector, one can use simpler, less expensive pumps to deliver
solvents and take advantage of the exponential dilution [52J that occurs in the dead
volumes to produce useful chromatographic gradients at flow rates less than 1
j.tL/min.
By pursuing this later alternative, I constructed an exponential gradient nano-LC
system and coupled it online to ESI-MS and off-line to MALDI and nanospray MS.19
A detailed description of the system [53] is presented in the second chapter of my
thesis.
1.6. BIOLOGICAL SYSTEMS INVESTIGATED
The research conducted for this thesis was focused on elucidating the DNA-binding
domains of E. coil uracil-DNA glycosilase and human replication protein A. The
following sections provide a short biological background on both of these proteins.
1.6.1.E.coli Uracil-DNA Glycosylase
Uracil-DNA glycosylase catalyzes the cleavage of the N-glycosylic bond that joins
the uracil base to the deoxyribose phosphate backbone of DNA. The enzyme
recognizes uracil residues present in DNA as a result of dUMP incorporation or of
deamination of cytosine and plays an important role in initiating the uracil-DNA
excision repair pathway [54].
Uracil-DNA glycosilase isolated fromE.coli (Ung) was the first enzyme of this
class to be purified to homogeneity. The native enzyme is a single polypeptide
containing 228 amino acids and has a relative molecular weight of Mr = 25,563 Da.The enzyme was purified according to the purification protocol described in
Chapter 3. Figure 1.3 shows the MALDI (1 .3A.) and nano-ESI-MS (1 .3B.) spectra
recorded for Ung.
1.6.2. Human Replication Protein A
Replication protein A (RPA) is a single-standed DNA-binding protein that is highly
conserved in eukaryotic cells. RPA was originally identified as a factor essential for
the replication of simian virus SV4O DNA in vitro and subsequently has also been
shown to play an important role in DNA repair and recombination [55]. Human
RPA (hRPA) is a heterotrimer comprising 70, 32 and 14 kDa subunits. The 70-kDa
subunit binds single-stranded DNA with high affinity and the DNA-binding
domain was located between amino acids 181 and 422 [56].
hRPA was purified according to the procedure described in Chapter 4 of this thesis.
Figure 1.4 displays the MALDI spectrum obtained for two of the protein's
subunits, hRPA14 (Mr=13,569 Da) and hRPA32 (Mr=29,330 Da). The third
subunit, bRPA7O, also present in the mixture according to SDS-PAGE analysis, did
not produce a signal probably because of the competitive nature of the MALDI
ionization process.5.00
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Figure 1.3. MALDI and nano-ESI mass spectra of Ung. (A) A solution of 36
pmoles/p.L of Ung was mixed with a matrix solution of saturated a-hydroxy-
cinnamic acid (HCCA) in a 1:3 ratio and analyzed by MALDI. Only singly
protonated (m/z = 25,563) and doubly protonated (m/z = 12,783) molecular ions
are be observed. (B) Nanospray MS spectrum obtained from a solution containing
36 pmo1es/tL of Ung dissolved in 50 % acetonitrile/water. The spectrum averages
40 spectra recorded on an ion trap mass spectrometer. A distribution of multiply
protonated molecular ions is observed.4.00
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Figure 1.4. MALDI spectrum of hRPA. The purified protein was denatured and solubilized in 50
mM Tris-base buffer (pH=8) at a concentration of about 10 pmoles/pL. hRPA solution was mixed
with a saturated solution of HCCA (in 50% acetonitrile) in a 1:2 ratio and analyzed by MALDI-
TOF. The signal at m/z = 13569 corresponds to the singly protonated molecular ion of the
unmodified subunit hRPA14. The signals at m/z29330 and m/z = 14667 are produced by the
single protonated and doubly protonated molecular ions of the phosphorylated subunit hRPA32. No
signal corresponding to the third subunit (70 kDa) was detected in the corresponding mass range.23
1.7. DNA SUBSTRATES
The DNA substrates used in our UV-crosslinking experiments were selected
according to the DNA-binding site size of Ung and bRPA and according to the
photocrosslinkingreactivity of nucleicacidsbases[17].Based on these
considerations, oligodeoxythymidinedT20was chosen as our DNA model for Ung,
whiledT30was preferred for hRPA.
Both oligonucleotides were synthesized and HPLC purified by the Biopolymer
Core Facility, at the University of Maryland in Baltimore, and their purity was
assessed by MALDI MS. Figure 1.5 shows the spectra recorded fordT20(1.5A.)
and fordT30(1.5B.).
1.8. RESEARCH OBJECTIVES
The studies of Barofsky and co-workers demonstrated the feasibility of using mass
spectrometry to investigate protein-DNA interactions[1,3,11-14, 57]. The
analytical methodology associated with analyzing nucleoprotein complexeswas
established using E. co/i uracil-DNA glycosylase (Ung) anddT20as a model system
[11-13]. One of the objectives of this thesis was to continue to investigate this
system and identify crosslinked amino acids from a peptide region(Ti8)that
appeared to have more than one amino acid interacting with the DNA substrate.12
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Figure 1.5. MALDI spectra ofdT20anddT30.(A) A solution of 108 pmoles/pL
of dT20 was mixed with a saturated matrix solution of 2,4,6-trihydroxy-
acetophenone (THAP) in a 1:10 ratio and analyzed by MALDI. (B) A solution of
45 pmoles/pL ofdT30was mixed with a saturated matrix solution of THAP in a
1:5 ratio and analyzed by MALDI. Singly protonated and doubly protonated
molecular ions are observed for both oligonucleotides25
The results obtained for Ung are presented in Chapter 3 on this thesis.
Another objective was to test the general applicability of our approach for
characterizing the DNA-binding domains of other proteins. Chapter 4 describes a
study performed in order to investigate the DNA-binding domain of human
replication protein A (hRPA).
One of the critical components in achieving success in studying nucleoprotein
complexes by mass spectrometry is to employ highly sensitive, high-resolution
nanoscale chromatographic techniques coupled to MALDI or electrospray MS.
Since no commercial nano-LC systems were available in 1998, at the beginning of
this project, I had to design and construct such a system [53]. This task became an
intermediate objective for my thesis. The results obtained for the Ung project
(Chapter 3) demonstrated that a high-resolution chromatographic system was
indeed required to separate three nucleopeptide isomers. The details involved in
designing such a system are presented in the second chapter of this thesis.26
2. DESIGN OF THE NANO-LC SYSTEM
Reproduced with permission from Doneanu, C.E., Griffin, D.A., Barofsky, E.L.,
and Barofsky, D.F, I Am. Soc.Mass Spec., 2001, 12, 1205-1213.Copyright2001,
Elsevier Science Inc., New York.
2.1.INTRODUCTION
The development of highly sensitive matrix-assisted laser desorptionlionization
(MALDI) and electrospray ionization (ESI) mass spectrometric techniques for the
analysis of peptides, proteins, and other biomolecules during the last decade
generated the concomitant development of miniaturized separation techniques.
Liquid chromatography at flow rates under 1L/min using packed fused-silica
columns with inner diameters less than 100 p.m was introduced in the early eighties
by McGuffin and Novotny [47] and independently studied over the next dozen or
so years by Karlsson and Novotny[58]and by Kennedy and Jorgenson[59,60].In
principle, such minimization should significantly increase mass sensitivity and
separation efficiency. By1991,it had been demonstrated that chromatography on
this scale could be directly coupled to a mass spectrometer using a coaxial,
continuous-flow, fast atom bombardment interface[61],and only two years later, it
was shown that the same could be done with a micro-ESI interface[48,62].The27
term nano-LC was introduced to describe chromatographic separations performed
at flow rates in the range of 10-1000 nL/min on packed fused silica columns with
inner diameters between 10 and 150 p.m [50,61].
In order to exploit the advantages of nano-LC, itis necessary to have a
micropumping system that can provide gradient elution at flow rates below 1
p.L/min while maintaining accurate proportioning, homogeneous mixing with
minimal delay, and reproducible delivery of the mobile phase. Commercial HPLC
systems, e.g. the Agilent 1100, that can do this directly have became available very
recently, but the most conmion way to achieve gradient elution in the nano-LC
domain at present is to insert a flow-splifter between a conventional HPLC solvent
delivery system and a nanocolumn. The inlet ports of most microinjectors designed
for capillary LC applications operating at flow rates of 5-10 p.L/min have dead
volumes between 5-15p.L.In nano-LC applications, dead volumes of this
magnitude act as mixing chambers that introduce delays in establishing the gradient
and alter the delivery system's gradient profile through solvent-mixing. Rather than
taking inordinate measures to minimize the unavoidable dead volumes between the
splitting point and the microinjector, one can use simpler, less expensive pumps to
deliver solvents and take advantage of the exponential dilution [52] that occurs in
the dead volumes to produce useful chromatographic gradients at flow rates less
than 1 p.L/min.
This alternative was pursued in our present work by constructing an exponential
gradient nano-LC system from inexpensive components and examining its potential28
for being used in combination with MALDI or Nano-ESI mass spectrometry to
separate and analyze the peptides in an enzymatic digest ofEscherichia coliuracil-
DNA glycosylase (Ung). Uracil-DNA glycosylase is one of five proteins that
participate in the uracil-excision DNA repair process, the major cellular defense
mechanism against spontaneous DNA damage. The enzyme begins the repair
process by catalyzing the cleavage of the N-glycosidic bond that joins uracil to the
deoxyribose phosphate backbone of DNA [54]. Native Ung, which was the first
enzyme of its class to be purified to homogeneity, is a single polypeptide consisting
of 228 amino acids(M1= 25,563). The results of this work demonstrate that an
uncomplicated approach to nano-LC can be applied in both on- and off-line
applications of protein analysis to produce useful data when more sophisticated but
expensive commercial instrumentation is unavailable.
2.2. EXPERIMENTAL
2.2.1. Materials
Peptide standards, acetic acid (AA) and trifluoroacetic acid (TFA) were obtained
from Sigma Chemical Co. (St Louis, MO). HPLC grade acetonitrilewas purchasedfrom Fisher Scientific (Pittsburgh, PA). Water was generated with a Mili-Q water
purification system (Milipore Corp., Bedford, MA).
2.2.2. Sample Preparation
Uracil-DNA glycosylase expressed in E. coli (Ung) was purified as described by
Bennett and Mosbaugh [63].Denatured protein was analyzed by 12.5%
polyacrylamide SDS slab-gel electrophoresis according to a previously published
method [3]. Protein bands, identified by staining the gel with 300 mM copper
chloride for 5 mm, were cut out ( 100 pmoles proteinlgel slice), placed in 1.5 mL
Eppendorf tubes, and destained by rinsing 4 times on a vortex mixer with
destaining solution (Bio-.Rad, Hercules, CA). Each rinsing step was carried out for
15 mm. In-gel protein digestion was performed according to a modified procedure
introduced by Shevcenko et al. [64]. Gel slices were prepared for in-gel proteolytic
digestion by washing them with 100 mM ammonium bicarbonate, dehydrating with
100% acetonitrile, rehydrating with bicarbonate solution, and dehydrating again
with 100% acetonitrile. Each gel preparation step was carried out for 15 mm with
vortexing. After removing the liquid phase and drying under vacuum for 3 hours,
the gel-slices were placed in 0.6 mL Eppendorf tubes and covered with 200 pL of
digestion buffer (50 mM ammonium bicarbonate,1 mM calcium chloride)
containing 36 ng/jiL trypsin (Boehringer, Mannheim, Germany). The tubes were30
placed in an ice bath for one hour after which the supernatant was removed and
replaced with 50 il of digestion buffer without enzyme. After allowing enzymatic
cleavage to proceed overnight at 37 °C, the volume of the digestion buffer collected
from 6 digested gel pieces was reduced to about 50 pL under vacuum to yield a
final peptide concentration of 5-10 pmoles/jL. This preparation provided a
sufficient peptide sample for several mass spectrometric experiments.
2.2.3. Column Preparation
The nano-LC columns were prepared by packing 20 cm lengths of 360 pm o.d. x
75 pm i.d. fused-silica (Polymicro Technology (Phoenix, AZ) with 5 .tm, 300A
pore, LunaC18silica gel particles (Phenomenex, Torrance, CA) using a pressurized
bomb method described by Kennedy and Jorgensen [59]. In short, the end of the
silica capillary that is to become the inlet is slipped through a seal into the bomb
containing a slurry of isopropanol and the packing material (25 mg!mL); the outlet
of the column is inserted into a Valco (Houston, TX) microbore end-fitting
containing a 2 tm Valco metallic screen that acts as a temporary outlet frit. The
packing material is forced into the capillary by pressurizing the bomb to 1,500 psi;
about two hours are required to pack a 20 cm long column. After the gas pressure is
slowly released from the bomb, the inlet of the column is connected to an HPLC
pump and flushed with acetonitrile for 2 hours and Milli-Q water for another 231
hours. A fused-silica splicer (Fujikura, Japan) is used to prepare the final outlet frit
while the column is still wet. The column is left without an inlet frit because this
end must be occasionally trimmed to eliminate plugging by very small gel pieces
from the in-gel protein digests.
2.2.4. Nano-LC System
Figure 2.1 shows a schematic of the nano-LC system. For LC/UV chromatography,
solvents A and B were respectively 0.04 % TFA in water and 0.04 % TFA in 40 %
acetonitrile, and for LC/MS chromatography, solvents A and B were respectively
0.1 % AA plus 0.01 % TFA in water and 0.1 % AA plus 0.01 % TFA in 40 %
acetonitrile. Since an elution gradient is produced by introducing solvents A and B
serially into the two mixing chambers, it suffices to use only one pump at a time to
isocratically deliver the respective solvents. For convenience, two conventional
HPLC pumps (Kratos Analytical Spectroflow 400, Ramsey, NJ) were used for this
purpose. The solvents were each delivered at 3050 tL/min. From the pump,
solvent passes through an inline filter (Kratos Analytical, Ramsey, NJ) into a flow-
splitter. The filter helps avoid clogging of the system downstream. The flow-splitter
comprises a PEEK T-piece (Upchurch Scientific, Murrieta, CA), a 30 tm i.d x 50
cm fused-silica waste-line that functions as a flow resistor, and a 60 jim i.d x 5 cm
PEEK connecting line to thefirst mixing chamber. The split-ratio of this32
arrangement is between 1:50 and 1:100 so the flow through the analytical column is
in the range 300-1000 nL/min. A ZDV PEEK union (Upchurch Scientific,
Murrieta, CA) drilled out to an internal volume of 3 L was used as the first mixing
chamber of the exponential gradient elution system, and the inlet port of the
injection valve served as the second mixing chamber.
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Figure 2.1. Schematic of the nano-LC system: (1) solvent delivery pumps, (2)
inline filter, (3) flow splitter, (4) restriction capillary, (5) 3 jL mixing chamber; (6)
ioop injector (12 pL mixing chamber), (7) nanocolumn, (8) transfer capillary, and
(9) UV detector.33
A micro-injection valve with a port-volume in the range of 8-12 pL (Rheodyne
Model 7520, Rohnert Park, CA) was used with a 1 p.L internal sample injection
loop for on-line nano-LC/MS whereas an injector with an internal volume of about
10 j.iL (Rheodyne Model 8125, Rohnert Park, CA) was used with a sample
injection loop of 5 jiL for off-line nano-LC/MS. PEEK tubing with 60 pm i.d. was
used to coimect the pumps to the filter, splitter, mixing chamber, and injector. The
inlet of the 75 jim i.d. x 20 cm nanocolunm was attached directly into the injector's
outletport.The outlet of the nanocolumn was connected via a 30 p.m i.d. x 20 cm
fused-silica transfer line to a capillary electrophoresis (CE) unit (Beckmann P/ACE
System 2210, Fullerton, CA) to provide UV detection and data acquisition
capabilities for the system. The nanocolunm was attached to the transfer capillary
with a short piece of Teflon tubing; the length of the transfer capillary from the
outlet of the nanocolunm up to the detector was 13 cm. A small diameter hole was
drilled in the upper part the CE unit's cartridge (the housing that holds the capillary
in place) to allow the packed capillary colunm to be connected to the transfer line
inside the cartridge. A small hole, aligned with the hole in the cartridge, was also
drilled in the upper right part of the cartridge interface of the CE unit.
Samples were loaded from the injection valve onto the nanocolunm by connecting
pump A to the system and raising the inlet pressure to 200 bar so the sample was
displaced from the injection loop by solvent A onto the column at a flow rate of
1.2 p.L/min. After allowing sufficient time to completely displace the sample from34
the injection loop (-l0 mm), pump A was stopped and, after allowing the pressure
to drop to 1 bar, disconnected from the system. Pump B was then connected to the
system, and the inlet pressure was raised to 100 bar to deliver solvent B at 0.5
p.L/min.
2.2.5. Mass Spectrometry
MALDI-TOF MS analyses were performed on a custom built instrument [1]
equipped with delayed extraction and an ion mirror. For analysis of a protein-
digest, 1iL of a 1:3 (v:v) mixture of peptide solution (0.5 jtL) and a saturated
solution of a-cyano-4-hydroxycinnamic acid (Sigma, St. Louis, MO) in 50 %
acetonitrile) was spotted on the MALDI probe. The instrument was operated in the
positive ion mode with an accelerating potential of 20 kV and an extraction delay
of 500 ns. A spectrum was produced by using MoverZ software (ProteoMetrics,
LLC, http://www.proteometrics.com/ soflware/mz.htm) to collect and average data
generated from 30 laser pulses.
Nano-ESI MS analyses were performed on two different instruments: an API III
triple-quadrupole (PE-Sciex, Ontario, Canada) and an LC-Q ion trap (Finnigan, San
Jose, CA). A custom built nanospray assembly [40] was designedso that, with
minor adjustments, it can be operated on either instrument. For analysis ofa
protein-digest, 1 1iL from each chromatographic fractionwas loaded in a nanospray35
capillary purchased from Protana (Odense, Denmark). The API-Ill was operated
with the needle set at 750 V, the interface at 100 V, the orifice electrode at 60 V,
and the curtain gas flow at 0.4 L/min. In the MS-mode, Qi was scanned in steps of
0A Da with a 1.5 ms dwell time. For operation in the MS/MS-mode, Qi was set to
transmit a 2 Da-mass window centered on the precursor ion, and product ion
spectra were recorded by scanning Q3 in steps of 0.2 Da with a 3 ms dwell time.
The LC-Q was operated in the MS-mode with the needle potential set to 900 V, the
temperature of the heated inlet-capillary at 180 °C, the capillary potential at 46 V,
the tube-lens offset-potential at 30 V, and the maximum injection time was 50 ms.
For operation in the MS/MS-mode, the maximum injection time was increased to
500 ms, the isolation width was set to 1 Da, and the collision energy was tuned
individually for each peptide to obtained the best possible MS/MS spectra. MS/MS
spectra from both instruments were interpreted with the aid of MS-Tag software
(University of CaliforniaatSanFrancisco,Mass SpectrometryFacility,
http.//prospector. ucsfeduf).
On-line nano-LC/ESI MS was performed using a custom built micro-electrospray
source installed on the LC-Q instrument. A short piece of Teflon tubing was used
to couple the packed fused-silica column to a New Objective (Cambridge, MA)
fused-silica, coated needle (360 p.m o.d. x 50 p.m i.d. x 5 cm, 30 p.m tip). During
operation, the needle potential was set at 2.6 kV.2.3. RESULTS AND DISCUSSION
2.3.1. On-line Nano-LC/MS
A continuous exponential gradient from 0 to 100% solvent B will emerge from a
chamber initially filled with solvent A if the later is displaced from the chamber by
an equal volume of solvent B delivered at a constant flow rate [52]. More
specifically, the concentration Bsjngje(t) of solvent B in the mobile phase exiting a
single mixing chamber of volumeV1is given at any time t, after solvent B begins
to enter the chamber, by the exponential expression
Bsingie(t) = B0 (1-et1) (2.1.)
where B0 is the concentration of solvent B in the mobile phase used to displace
solvent A from the mixing chamber andv1 = V1I F is the time it takes to displace
solvent A. When two mixing chambers with volumesV1andV2respectively are
connected in series (as in Figure 2.2), Bsingie(t) at the outlet of the first mixing
chamber becomes the initial concentration of the mobile phase entering the second
chamber. In this case, the differential equation for the rate of increase of B in the37
mobile phase exiting the second chamber can be shown to reduce to the following
simple formula:
dB(t)B (t)_B(t)
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Figure 2.2. Two mixing chambers having different volumes V1 and V2
connected in series. Ti and t2 are the times it takes to displace volumes Vi and V2
of solvent A from chambers 1 and 2 respectively.38
Solving equation (2.2.) yields the following formula for the time dependent
concentration BdoubIe(t) of solvent B exiting the second mixing chamber:
B(t)=Bri_
double 0 L
__t-
1 ('r2 e2 E1et1)]
-
(2.3.)
Figure 2.3A shows the theoretical shapes obtained for 4 different gradients
produced at a flow rate of 0.5 tL/min by two mixing chambers. In all four cases,
the volume of the first mixing chamber was 3tL, but the volume of the second
mixing chamber was respectively 5, 10, 12, and 15 pL. Figure 2.3B exhibits the
corresponding experimental profile obtained by monitoring the increase in UV
absorbance as solvent B spiked with 10% acetone (v/v) elutes from the nano-LC
system pictured in Figure 2.1. The onset of the curve in Figure 2.3B indicates a
delay of around 10 mmin establishing the gradient. Comparison of Figure 2.3A
and 2.3B, with allowance for the 10 mm delay in time in the experimental curve,
indicates a close match between the shape of the experimental gradient and the
shape of the theoretical gradient withV1= 3L andV2= 10 j.iL. This degree of
agreement signifies that mixing of the solvents in both chambers was nearly
homogeneous.Gradient reproducibility was measured by three consecutive injections of a Ung
tryptic digest sample. The nano-LC/MS base peak chromatograms obtained are
shown in Figure 2.4.
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Figure 2.4. Nano-LC/ion trap base-peak ion-chromatograms of a tryptic digest
of Ung obtained for three consecutive runs. Based on Ung's 20 theoretically
possible tryptic fragments, the peptides are labeled T (n1,20) from the N
terminal; peptides containing missed tryptic cleavage sites are labelled Tin+i
(n=l,20). Each chromatogram was produced by injecting 1tL of tryptic digest (5-
10 pmoles/p.L onto the colunm (75 tm i.d x 20 cm; 5 pmC18)and eluting at 0.5
pL/min (pressure at inlet filter = 100 bar) with an exponentially produced gradient
of 0% to 40% Solvent B (0.1 % AA plus 0.01% TFA in 40 % acetonitrile). Ion
detection was from m/z 300 to 2000.
6041
Peptide samples serve as a sensitive monitor for gradient reproducibility because
even minor changes in gradient composition result in detectable variations in
retention time [65]. The adjusted retention time and the corresponding mean and
relative standard deviation (RSD) for each of seven major peptides seen in the
chromato grams are listed in Table 2.1. Although the RSD obviously increases
systematically with increasing retention time, it remains below ± 0.3 % (n = 3) for
adjusted retention times up to at least 20 minutes. Thus, the reproducibility of the
gradient profile from run to run is analytically useful and indicates a high level of
performance for the entire nano-LC system.
Peptide
Run T3 T5 Til mT2 T4 T819 T2
1 4.3 4.93 9.86 10.75 11.76 15.63 19.99
2 4.26 4.88 9.83 10.74 11.69 15.93 20.42
3 4.32 5 9.92 10.87 11.92 15.89 20.46
Mean
(mm)
4.29 4.94 9.87 10.79 11.79 15.82 20.29
RSD(%) 0.03 0.06 0.05 0.07 0.12 0.16 0.26
Table 2.1. Adjusted retention times in minutes calculated for seven major Ung
tryptic peptides and the corresponding means and relative standard deviations
(RSD). (Adjusted retention time = retention time for n' peptideretention time for
T18 peptide.)42
The nano-LC/UV chromatogram of the same sample under identical gradient
conditions is exhibited in Figure 2.5. The sensitivity is not as great as would be
obtained with a conventional UV-detector, because a very short path length (30
p.m) is used for the nano-LC system. The baseline absorbance in this chromatogram
gradually decreases with increasing time as acetonitrile from solvent B replaces
water from solvent A.
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Figure 2.5. Nano-LCIUV chromatogram of a Ung tryptic digest. Based on
Ung's 20 theoretically possible tryptic fragments, the peptides are labeled T
(n=l ,20) from the N terminal; peptides containing missed tryptic cleavage sites are
labelledT1+1(n=1,20). The chromatogram was produced by injecting 1 p.L of
tryptic digest (5-10 pmoles/jtL) onto the column (75 tm i.d x 20 cm; 5 i.mC18)and
eluting at 0.5 iL/min (pressure at inlet filter = 100 bar) with an exponetially
produced gradient of 0% to 40% Solvent B (0.04% TFA in 40 % acetonitrile). UV
detection was at 200 nm.43
The peaks in the ion chromatograms are broader than the corresponding peaks in
the UV chromatogram for two reasons. First, the level of TFA in the ion pairing
agent employed in the LC/MS runs (0.1 % AA plus 0.01 % TFA) was lower than in
the LC/UV runs (0.04 % TFA) because TFA suppresses peptide ion formation in
electrospray ionization and, thus, degrades sensitivity. With less TFA present in the
LC/MS mobile phase, ion pairing among the peptides is reduced, and consequently
the peptide's chromatographic peaks are broader. Second, an additional dead
volume is introduced into the LC/MS runs through the coupling between the
nanocolumn and the spraying needle.
Of the 20 tryptic fragments theoretically possible for Ung, 15 were identified from
the mass spectra that compose the ion chromatograms in Figure 2.4. As is typical
for tryptic digests, the missing peptides are either very short (e.g.,T14is K and116
is QR) or very long (e.g., the molecular weight ofT617is over 3,000 Da). The small
peptides cannot be efficiently trapped during injection onto the column, and the big
peptides (> 3,000 Da) are not extracted into the digestion buffer. The incomplete
digestion of13/4is presumably due to steric hindrance whereas that of peptidesT617
andT819is due to the well known fact that trypsin does not efficiently cleave R-P
bonds. The only cysteine in Ung, which appears inT19,was acrylamide modified
[3].44
2.3.2. Off-line Nano-LC/MS
Numerous instances arestill encountered in mass spectrometric analyses of
proteins in which limited sample amounts or diluted sample solutions make it
necessary toisolate or concentrate certain peptides contained in complex
proteolytic mixtures in order to analyze them further by MALDI-TOF MS and
nano-ESI MS/MS. In particular, MS/MS analysis of a peptide requires that the
collision energy be tuned properly in order to obtain adequate sequencing
information for identification. Generally in nano-LC/MS, the width of a peptide's
elution profile at the outlet of the column is in the range of 7- 15 s; this is too little
time to allow for optimal adjustment of the MS/MS collision energy for a peptide
as it elutes off the column. Consequently, an enzymatic digest of a protein is
usually systematically analyzed at different collision energies in a progression of
experiments in order to obtain sufficient sequence information from as many of the
peptides as possible. This problem, which is associated with the narrowness of the
chromatographic peaks, is compounded when peptides coelute. To overcome these
problems, David and Lee introduced the concept of variable-flow nanoscale
separation in which peptides are separated at 200 nL/min but MS/MS analysis is
performed at a "peak parking" rate of 25 nL/min [51]. When a digest contains a
particularly large number of peptides or a cluster of several peptides that only
partially separate on the column, this approach can fail to produce the desired
sequencing data. In such situations, nanospray MS/MS analysis can be more45
practicable. The nanospray signal from a single sample of a protein digest typically
lasts for periods of 20-30 mm, which is generally ample time to determine the
optimum collision energy and record the MS/MS spectrum for each of many
peptides [39,40,66,67]. If a digest contains a larger than usual number of peptides
however, even this method can be improved by fractionating the sample off-line on
a nano-LC column and loading the individual fractions into nanospray tips.
Figure 2.6 shows a chromatogram produced by overloading the column with 10 pL
of a Ung tryptic digest. The broad widths of the peaks are a clear indication of the
excessive amount of sample on the column. In spite of this gross condition, peptidic
separation was sufficient to permit collection of 15 well defined peptide fractions.
Each of these fractions was analyzed by MALDI MS and nano-ESI MS to assess
the degree of peptide-isolation and to tentatively assign peptide-identity. The
MALDI and nanosprayed ion trap mass spectra of Fractions number 3,7,8, and 12
are displayed in Figure 2.7. Except for a general tendency to shift the distribution
of charge states upward, the triple-quadrupole produced nanosprayed spectra (data
not shown) that are similar in appearance to those recorded on the ion trap.10
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Figure 2.6. Nano-LCIUV chromatogram produced by loading the column with
10 p.L of a tryptic digest of Ung in two, consecutive, 5-p.L injections. The
sample was eluted at 0.5 iL/min (pressure at inlet filter = 100 bar) with an
exponentially produced gradient of 0% to -40% Solvent B (0.04% TFA in 40 %
acetonitrile). UV detection was at 200 nm. Fifteen fractions (labeled 1 through 15
in the order of collection) were collected manually; fraction volume varied from 2-
3 p.L depending on the collection period (2 to 4 mm). 1 p.L of solvent A (0.4 %
TFA in water) was added to each collection vial before starting the manual
collection.
Comparison of Figure 2.6 with Figure 2.5 suggests that Fractions 3 and 12, which
were collected respectively from segments of the chromatogram corresponding to
well isolated components, should contain essentially only a single peptide whereas47
Fractions 7 and 8, which were taken from segments corresponding to crowded,
incompletely separated components, should contain at least a couple of peptides.
The mass spectra shown in Figure 2.7 are in accordance with this expectation.
Specifically, the spectra indicate the presence of only Ung-Tis in Fraction 3 (Figure
2.7A) and, for most part, Ung-T2 in Fraction 12 (Figure 2.7D) but of Ung-T4 plus a
non-tryptic component in Fraction 7 (Figure 2.7B) and Ung-Ti plusUng-T19in
Fraction 8 (Figure 2.7C). There were no traces of contamination in either the
MALDI or nano-ESI mass spectra of any of the 15 fractions. The MALDI spectra
shown in Figure 2.7 suggest that the nano-LC separation technique described in this
paper might be particularly well suited to on-line coupling to a MALDI source
through a vacuum deposition interface like that recently introduced by Preisler et
al. [68,69].48
Figure 2.7. MALDI and Nano-ESI mass spectra obtained from Fraction 3
(2.7A.), Fraction 7 (2.7B.), Fraction 8 (2.7C.), and Fraction 12 (2.7D.)
respectively of the chromatographic collection indicated in Figure 2.6. The
Nano-ESI spectra were recorded on the ion trap mass spectrometer.MALDI
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Figure 2.7A. MALDI and nano-ESI mass spectra obtained from Fraction 3.20
Intensity
RIiv bndno
0t I --"r
800 m/z 1800
Figure 2.7B. MALDI and Nano-ESI mass spectra obtained from Fraction 7.70
Intensity
0 #-- rrr p
1000 mlz 3000
Figure 2.7C. MALDI and Nano-ESI mass spectra obtained from Fraction 8.70
Intensity
Relative abundance
0 -i t--- - -t r
1000 mlz 3000
Figure 2.7D. MALDI and Nano-ESI mass spectra obtained from Fraction 12.53
The ESI spectra in Figure 2.7 demonstrate that the nano-LC system fractionates
complex mixtures into clean samples for nano-ESI MS even under conditions of
excessive sample loading.
Nano-ESI MS/MS spectra of the components in all 15 of the nano-LC fractions of
the Ung-tryptic digest were recorded on both ion trap and the triple-quadrupole
instruments to confirm peptide-identity. Figure 2.8A displays the MS/MS spectra
obtained off both instruments from the single component contained in Fraction 3.
Although the ion trap spectrum was produced from the singly charged molecular
ion (m/z = 1169.7) and the triple quadrupole spectrum was obtained from the
doubly charged molecular ion (m/z = 585.4),both mass spectraexhibit
predominantly y-ions. As can be seen from the fragmentation diagram atop the ion
trap spectrum, the information generated from this particular peptide, despite the
instrument's low-mass cutoff at '-m/z 300 {70], is sufficient to assign the sequence
of all of its amino acid residues and identify it asT18(APHPSPLSAHR). By
contrast, the sequence information obtained off the triple-quadrupole in this case is
incomplete. The later would, nonetheless, be sufficient to identify the peptide by
searching a database. The non-tryptic peptide in Fraction 7 was one of several
unknowns fortuitously provided by the Ung tryptic digest. Figure 2.8B shows the
nanosprayed MS/MS spectra of the doubly charged ion (m/z690.3) of this
molecule obtained respectively from the ion trap and the quadrupole instruments.54
Figure 2.8. Ion trap and triple-quadrupole MS/MS spectra obtained from
Fraction 3 (2.8A.) and Fraction 7 (2.8B.) respectively of the chromatographic
collections indicated in Figure 2.6. The precursors for the ion trap spectrum (50 %
collision energy) and triple quadrupole spectrum (20 eV collision energy) from
Fraction 3 were respectively the singly charged ion at m/z1 169.7 and the doubly
charged ion at m/z= 585.4. The precursor for the ion trap spectrum (20 % collision
energy) and triple quadrupole spectrum (25 eV collision energy) from Fraction 7
was the doubly charged ion at m/z= 690.3. MS-Tag analyses of the sequencing data
provided by the mass spectra are summarized in the fragmentation diagrams
displayed at the top of each spectrum.Yb Y9 Y8 Y7 Y6 Y5 y4
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Figure 2.8A. Ion trap and triple-quadrupole MS/MS spectra obtained from Fraction 3.Yb Y7 Y4 Y3
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Figure 2.8B. Ion trap and triple-quadrupole MS/MS spectra obtained from Fraction 7.57
The MS/MS spectrum produced by the ion trap contains almost exclusively b-ions
while that recorded on the triple quadrupole exhibits mostly y-ions. As seen from
the fragmentation diagrams for these two mass spectra, the sequence information
from either spectrum was adequate for MS-Tag to identify the unknown peptide as
the fragment (FLNTLQTVASER) that is formed by the loss of the first four amino
acid residues (QQPY) from the N terminal ofT2.MS/MS analysis (data not shown)
was used in a similar manner to verify that the relatively intense ion signal at m/z =
1878.8 in the MALDI mass spectrum of Fraction 12 (Figure 2.7D) corresponds to
the pyroglutamic acid form ofT2created by the elimination of ammonia from its N
terminal glutamine.
An off-line batch technique cannot match an on-line alternative for convenience,
but in those not infrequent instances where a protein defies routine, directly
coupled HPLC/ESI MS/MS analysis, off-line nano-LC/nano-ESI MS/MS can
provide a critical, complementary aid to identifying the protein. The two examples
described in the preceding paragraph indicate how nano-LC might be used in
situations where isolation of specific peptides from complex proteolytic digests is
necessary in order to perform nano-ESI MS/MS or possibly MS under optimum
collision conditions. ESI analyses in the MS and MS/MS modes typically requires
mid-femtomole to low picomole amounts of sample on both ion trap and triple
quadrupole instruments- lower levels are possible but not routine at present [70].58
Fractionation by nano-LC does not measurably degrade this sensitivity because
opportunity for sample contamination is minimal and additional concentrating steps
are unnecessary.59
3. IDENTIFICATION OF AMINO ACID RESIDUES
IN THE DNA-BINDING DOMAIN OF
URACIL-.DNA GLYCOSYLASE FROM E. COLI
Reproduced with permission from Doneanu, C.E., Gafken, P.R., Bennett, S.E., and
Barofsky, D.F,Anal. Chem.,submitted.
3.1. INTRODUCTION
A central aim of molecular biology is to elucidate the molecular interactions that
occur between proteins and nucleic acids during replication, recombination,
dynamic alteration and repair of DNA, and transcription and regulation of genes.
Mass spectrometry in combination with photochemical/chemical crosslinking,
along with X-ray diffraction and NMR spectroscopy, is considered a direct method
that provides information about the structural relationship between proteins and
nucleic acids. The strategy, which combines low intensity UV crosslinking and
mass spectrometry, was initially demonstrated in 1994 [3]. The coupling of
photocrosslinking to mass spectrometry for protein-DNA analysis has become
increasingly popular in recent years [7-14,107]. Photochemically crosslinking
nucleic acid binding proteins to their substrates is an established procedure for
characterizing protein-nucleic acid interfaces [17-19]. This technique uses photonsas "zero-length" crosslinkers to induce the formation of covalent bonds between
certain amino acids that are in close contact with nucleic acid bases. It is assumed
that only amino acids located in the protein binding site are involved in the
formation of these bonds. For the identification of amino acids that take part in the
crosslinking, enzymatic digestion of the UV-irradiated nucleoprotein complex is
used to produce free peptides and peptides crosslinked to the nucleic acid substrates
(nucleopeptides).Afterseparation from thenon-crosslinkedpeptides,the
crosslinked peptides are analyzed by MALDI-TOF in order to obtain their
molecular weights. By subtracting the mass of the nucleic acid from the mass of a
nucleopeptide and comparing the resulting mass to a peptide map of the non-
crosslinked protein, one can identify a region in the protein containing the peptides
involved in crosslinking. This straightforward strategy can be used only if the
chemistry of the photochemical reaction is known. In the final stage of analysis, the
nucleopeptides are sequenced by tandem mass spectrometry (MS/MS) in order to
identify the amino acids attached to nucleic acid bases.
In this paper, photochemical crosslinking and mass spectrometry have been used to
investigate the DNA-binding domain of E. coli uracil-DNA glycosylase (Ung), one
of many enzymes involved in DNA repair processes. DNA repair is an essential
process for maintaining the integrity of the genome. In the simplest type of DNA
repair, the damaged base is repaired directly, e.g. dealkylated, by a one-step
mechanism rather than being excised and replaced by a correct one. However, most
lesions in DNA are repaired by the much more complex recombination repair or61
excision repair systems. The latter include nucleotide excision repair (NEP),
mismatch repair and base excision repair (BER). As the name implies, the initial
step in BER is the removal of a base by DNA glycosylases rather than removal of
an entire nucleotide. DNA glycosylases are relatively small monomeric proteins
that do not require cofactors for their activity; therefore, they are good models for
studying interactions between DNA and proteins. Uracil-DNA glycosylase is an
enzyme involved in the uracil excision repair mechanism. It is widespread and
highly conserved among biological species. A uracil base is introduced into DNA
either when a deoxyuridine triphosphate (dUTP) is incorporated during DNA
replication instead of a thymidine triphospahte (TTP), or when a cytosine is
deaminated. AboutiO4uracil bases are incorporated into human DNA following S-
phase DNA synthesis, and spontaneous cytosine deamination occurs at a rate of
200 events per human cell per day [54]. Cytosine deamination is a major mutagenic
force because it produces a CD to AT transition. The major cellular defense
mechanism against this form of spontaneous DNA damage is a multistep uracil-
excision DNA repair process. In the first step of this repair pathway, uracil-DNA
glycosylase catalyzes the hydrolysis of uracil residues from single-stranded or
double-stranded DNA, producing free uracil and abasic DNA. The abasic site is
subsequently removed by a 5'-acting apurinic/apyrimidinic (AP) endonuclease and
a deoxyribophosphodiesterase, leaving a gap that is filled by DNA polymerase and
closed by DNA ligase.62
Uracil-DNA glycosylase from E. coli (Ung) was the first DNA glycosylase
discovered [711. Subsequently, the E. coli ung gene was cloned and the protein was
overexpressed [72]. The deduced nucleotide sequence indicates that the protein is a
monomer containing 228 amino acid residues and has a relative molecular weight
of 25,563 Da. It is believed that Ung's primary function is to recognize and remove
uracil from UIG mispairs resulting from the deamination of cytosine [54,73,74].
The 3D structure of Ung has been investigated by X-ray crystallography. The first
published crystal structure (obtained at a resolution of 3.2 A) was for the enzyme
co-crystallized with the uracil-DNA glycosylase inhibitor protein (Ugi) [75]. The
experiment revealed that Ung is made up of a four-stranded parallel 13-sheet and 11
separate a-helices. Shortly after, the crystal structure of the Ung-Ugi complex was
solved for the native enzyme and a H187D mutant [76]. Finally, a high-resolution
crystal structure of free Ung (at 1.6 A resolution), and of Ung bound to uracil (1.5
A resolution) became available [77]. In addition to crystallography, Raman
spectroscopy [78] and NMR [79] have been used to investigate the mechanism of
uracil removal by Ung. It has been shown that in the case of human uracil-DNA
glycosylase, the protein undergoes a conformational change and "flips" the uracil
base out of the major groove of the DNA helix into the active site where enzymatic
interactions with the uracil base and deoxyribose can be made [80,81]. The same
mechanism has been observed for Ung [77], and a comparison of the amino acid
sequence alignment between E. coli and human uracil-DNA glycosylase has
revealed that Ung possesses 12 of the same 13 residues attributed to DNA
L63
interaction in the human enzyme [75,76]. These results indicate that Ung closely
resembles its human counterpart and that it should be regarded as a prototypical
enzyme. According to the crystal structure of Ung bound to uracil [77], a uracil-
recognition pocket is formed at the active site of the enzyme by the following
residues: Q63, D64, Y66, F77, N123 and H187. In addition to this active site,
hydrogen bond interactions observed between several serine residues (S88, Si 89
and S 192) and the phosphodiester groups located on a single strand of DNA,
appear to contribute to the base flipping mechanism [82]. Three other amino acids
(Hi34, Li9i and R195) have been shown to interact with the uracil substrate [77].
In previous studies performed in our lab, we used photochemical crosslinking in
combination with mass spectrometry to investigate the DNA-binding domain of
Ung [1,3,11-13]. In the {Ung : dT20} nucleoprotein complex, we identified three
tryptic peptides (T6,T11andT18)crosslinked to deoxythymidine dT20 [3,11,12].
Within T6, LCIESI-MS/MS definitely located Y66 and H67 as sites of crosslinking
[11,12]. In the present paper, we report our research efforts to identify crosslinked
amino acids withinT18.64
3.2. EXPERIMENTAL
3.2.1. Chemicals
Acetic acid (AA), trifluoroacetic acid (TFA), ampicillin, bromophenol blue,
calcium chloride, copper (II) chloride, ethylenediaminetetraacetic acid (EDTA),
formic acid, HEPES, sodium chloride, streptomycin sulfate, Trizma (Tris-base) and
Tris-HC1 were purchased from Sigma Chemical Co. (St Louis, MO). Acrylamide
(>99% pure), ammonium persulfate, 2-mercaptoethanol, his N,N' -methyl-bis-
acrylamide, and N,N,N'N' -tetramethylethylenediamine (TEMED) were obtained
from Bio-Rad (Hercules, CA). Ammonium sulfate, dithiothreitol (DTT), glycine,
isopropyl-3--thiogalactopyranoside (IPTG), and sodium dodecyl sulfate (SDS)
were bought from Life Technologies Inc. (Grand Island, NY). HPLC grade
acetonitrile, ammonium acetate, ammonium bicarbonate, ammonium hydroxide
(50%), glucose, hydrochloric acid, isopropanol, methanol, potassium chloride,
sodium carbonate, and sodium hydroxide were supplied by Fisher Scientific
(Pittsburgh, PA). Glycerol and potassium phosphate (dibasic and monobasic salts)
were purchased from J.T. Baker (Phillipsburg, NJ). Agar, tryptone and yeast extract
were supplied by Becton Dickinson (Franklin Lakes, NJ). Water was generated
with a Milli-Q water purification system (Millipore Corp., Bedford, MA).
Oligodeoxythymidine dT20, was synthesized by the Biopolymer Core Facility, at
the University of Maryland at Baltimore. To desalt the dT20, the lyophilized sample65
(approximately 5 limole) was resuspended in 1 mL of 10 mM triethylammonium
bicarbonate buffer (pH 7.2) and applied to a 1.79cm2 x10 cm Sephadex G-25
colunm equilibrated in the same buffer. The column was operated at 20 mL/h and
1.5-mi fractions were collected. Fractions were monitored spectrophotometrically
at 260 nm and the elution peak was pooled and quantified by using a molar
extinction coefficient fordT20ofc260 = 1.7 x1L/molcm. The pooled fraction
was analyzed by MALDI MS to check for incomplete synthesis products and then
subdivided into 1 or 1 .5-mL aliquots that were dried by vacuum centrifugation.
Each aliquot was dissolved in DAB buffer (30 mM Tris-HC1 (pH 7.4), 1 mM
dithiothreitol, 1 mM EDTA, 5% (w/v) glycerol) to a final concentration of 242
pmoles/.tL.
3.2.2. Purification of Uracil-DNA Glycosylase (Ung)
The purification of Ung was based on a procedure previously described [3]. E. coli
JM1O5/pSB1O51 were grown on LB plates (1% tryptone, 0.5% yeast extract, 1%
NaC1, and 1.5% agar) containing 0.0 1% ampicillin at 37 °C. An isolated colony
was selected and grown overnight in LB medium (1% tryptone, 0.5% yeast extract,
and 1% NaC1) containing 0.0 1% ampicillin at 37 °C. The saturated culture was
used to inoculate 6 liters (1:100) of LB medium containing 0.01% ampicillin. The
culture was shaken at 37 °C until the cell density reached an0D600of 0.8 at whichtime IPTG was added to a final concentration of 1 mM. The induced culture was
allowed to grow for an additional 3 h and the cells were collected by centrifugation
in a Sorvall GSA rotor at 5,000 rpm for 15 mmat 4 °C. The cell pellets were
stored at 80 °C until the start of purification.
The following purification steps were carried out at 4 °C. Cell pellets were thawed
and thoroughly resuspended in 240 mL of buffer TED (50 mM Tris-HC1 (pH 8.0),
1 mM EDTA, and 1 mM dithiothreitol). Cells were lysed by sonication, and
cellular debris was pelleted by centrifugation in a Sorvall SA-600 rotor at 10,000
rpm for 15 miSupernatant fractions were pooled, and an equal volume of 1.6%
(w/v) streptomycin sulfate in TED was added dropwise with stirring over 30 mm.
Stirring was allowed to continue for an additional 30 mm, after which time the
solutions were cleared by centrifugation in a Sorvail SA-600 rotor at 10,000 rpm
for 15 mm. The supernatant was adjusted to 70% ammonium sulfate to precipitate
the protein, and the mixture was allowed to stir for an additional 30 mill to ensure
complete precipitation. The precipitate was collected by centrifugation in a Sorvall
SA-600 rotor at 10,000 rpm for 15 mm. The precipitate was resuspended in 4 mL
of UE buffer (10 mM Hepes-KOH (pH 7.4), 10 mM 2-mercaptoethanol, 1 mM
EDTA, 1 M NaC1, 5% (w/v) glycerol) and dialyzed overnight against UE buffer.
The dialyzed sample was applied to a Sephadex G-75 column (6cm2 x88 cm)
equilibrated in UE buffer, eluted with the same buffer, and collected into 7-mL
fractions. Fractions containing uracil-DNA glycosylase activity were pooled,
diafiltrated with 1.4 L of HA buffer (10 mM potassium phosphate (pH 7.4), 1 mMdithiothreitol, and 200 mM KC1), and concentrated to30 mL with an Amicon
stirred cell (Millipore) under 55 psi of N2 gas using a YM1 0 membrane (Millipore).
The sample was applied to a hydroxylapatite colunm (4.9 cm2x15 cm),
equilibrated in HA buffer, eluted with the same buffer, and collected into 5-mL
fractions.Fractions containing uracil-DNA glycosylase activity were pooled and
dialyzed overnight against DAB buffer. The sample was applied to a single-
stranded DNA agarose column (19 cm2x44 cm) equilibrated in DAB buffer, and
7-mL fractions were collected. After washing with 5 column volumes of DAB, the
enzyme was eluted with DAB containing 150 mM NaC1. Fractions containing
enzyme activity were analyzed by denaturing polyacrylamide gel electrophoresis to
monitor the level of purity in each fraction, and those fractions considered to be
greater than 90% pure for uracil-DNA glycosylase were pooled, diafiltrated against
1.4 L of buffer DAB, and concentrated to 2.5 mg!ml using an Amicon stirred cell
under 55 psi of N2 gas and a YM1O membrane. The protein concentration was
determined spectrophotometrically by using a molar extinction coefficient of C280
4.2x iO4L/mol'cm for Ung. The purified protein was stored at 80 °C until used.
3.2.3. Preparative Crosslinking of Ung to dT20
Purified Ung (36 nmol) was combined with a 3-fold molar excess of dT20, and
DAB buffer was used to bring the final volume to 1 mL. The mixture was placed inLIJ
a 4-mL, capped, quartz, cuvette (NSG Precision Cells, Farmingdale, NY) and
equilibrated on ice for 15 mmprior to crosslinking. The cuvette was placed
lengthwise on a bed of ice, and irradiated with UV light (?m=254 nm) in a
Stratalinker 1800 (Stratagene, La Jolla, CA) for 15 mm. This solution was either
used immediately or stored at -80 °C until future use.
3.2.4. Isolation of Tryptic Peptides Crosslinked to dT20
Aliquots of the irradiated crosslinking mixture were loaded onto a 10% SDS
polyacrylamide gel and subjected to gel electrophoresis. After removing the
stacking gel, the lower 3-cm portion of the resolving gel corresponding to the
region of free dT20 was removed, and the remaining portion of gel was copper
stained [83]. Bands corresponding to UngxdT20 were cut from the gel with a
clean, sharp razorbiade and placed into 1.5 mL Eppendorff tubes. Gel slices were
in-gel digested with trypsin (36 ngluL) following the procedure of Shevchenko et
al. [64]. After 2 h of digestion at 37 °C, 400 jtL of digestion buffer was added to the
gel slices, and digestion was continued overnight. After overnight digestion, the
aqueous digestion solution was removed and saved. The organic extraction mixture
of FAPH (50% formic acid, 25% acetonitrile, 15% isopropyl alcohol, and 10%
water) was added to each tube until the gel pieces were covered, and the tubes were
vortexed at room temperature for 4 h. The extraction mixture was removed from
each tube and saved. Gel slices were then crushed and dehydrated with 200 L ofacetonitrile for 10 mm. The acetonitrile was removed, with care not to remove any
gel pieces, and added to the saved FAPH extraction solutions. The combined
organic solutions were concentrated to dryness by vacuum centrifugation. The
saved aqueous digestion solution was adjusted to 10 mM Tris-HC1 (pH 7.2), 1 mM
EDTA, and 100 mM sodium chloride (TE-100), and the dried organic extraction
fractions were resuspended with 250 jtL TE-100. Both the adjusted aqueous
digestion solution and the resuspended organic extraction solution were applied to a
NAC-52 anion exchange cartridge (Life Technologies Inc.) that had been activated
with 3 mL TE-2000 (TE buffer containing 2000 mM sodium chloride) and
equilibrated with 5 mL TE- 100. After sample loading, the cartridge was washed
with 5 mL TE- 100 and the peptidexdT20 fragments (nucleopeptides) were eluted
with 1 mL TE- 1000 directly into a Centricon-3 (Millipore) desalting cartridge. The
Centricon-3 was centrifuged at 6000xg. The eluate was desalted by washing the
Centricon-3 sequentially with 4.5 mL of water, 4.5 mL of 10 mM ammonium
acetate, and 3 mL of water. The washed sample was concentrated to 200 jL and
then transferred to a 750-pt Eppendorff tube and further concentrated to about 10
tL by vacuum centrifugation.70
3.2.5. Nuclease P1 Digestion
Nuclease P1 (Amersham Biosciences, Piscataway, NJ) was diluted with 50 mM
ammonium acetate p11=6.5 (0.04 activity units/pL). Digestion was conducted at 37
°C for 4 h, after mixing 1L of nuclease P1 solution with 1tL of nucleopeptide
sample.
3.2.6. Column Preparation
The nano-LC colunms were prepared by packing 20 cm lengths of 360 jim o.d. x
75 tm i.d. fused-silica (Polymicro Technology (Phoenix, AZ) with 5 jim, 300 A
pore, LunaC18silica gel particles (Phenomenex, Torrance, CA) using the
pressurized bomb method described by Kennedy and Jorgensen [60]. In short, the
end of the silica capillary that is to become the inlet is slipped through a seal into
the bomb containing a slurry of isopropanol and the packing material (25 mg/mL);
the outlet of the column is inserted into a Valco (Houston, TX) microbore end-
fitting containing a 2 tm Valco metallic screen that acts as a temporary outlet frit,
The packing material is forced into the capillary by pressurizing the bomb to 1,500
psi; about two hours are required to pack a 20 cm long column. After the gas
pressure is slowly released from the bomb, the inlet of the colunm is connected to
an HPLC pump and flushed with acetonitrile for 2 hours and Mili-Q water for71
another 2 hours. A fused-silica splicer (Fujikura, Japan) is used to prepare the final
outlet frit while the colunm is still wet.
For on-line nano-LC/ESI MS a fused-silica column with an integral fit - "PicoFrit"
(360 pm o.d. x 75 tm i.d. x 40 cm, 15 pm tip) obtained from New Objective
(Cambridge, MA) was packed using the same procedure described above. The
column was connected to an injector (Rheodyne Model 8125, Rohnert Park, CA)
placed in a plastic box, and the spraying voltage (2.5 kV) was applied to the
injector after the sample was injected.
3.2.7. Nano-LC System
The nano-LC system employed uses the exponential dilution method to produce
gradient separations. A detailed description of the operating principle and system
setup is provided elsewhere [53]. Elution gradients are produced by exponential
dilution in two mixing chambers. Two conventional HPLC pumps (Kratos
Analytical Spectroflow 400, Ramsey, NJ) were used, one to deliver solvent A (0.04
% TFA in water for LC/UV runs or 0.1 % AA plus 0.01 % TFA for LC/MS runs)
and the other to deliver solvent B (0.04 % TFA in 40 % acetonitrile for LC!UV
runs or 0.1 % AA plus 0.01 % TFA for LC/MS runs). From the pump, solvent is
passed through an inline filter (Kratos Analytical, Ramsey, NJ) into a flow-splitter.
The filter helps avoid clogging of the system downstream. The flow-splitter72
comprises a PEEK T-piece (Upchurch Scientific, Murrieta, CA), a 30 p.m i.d x 50
cm fused-silica waste-line that functions as a flow resistor, and a 60 p.m i.d x 5 cm
PEEK connecting line to thefirst mixing chamber. The split-ratio of this
arrangement is between 1:50 and 1:100 so the flow through the analytical column is
in the range 300-1000 nL/min. A ZDV PEEK union (Upchurch Scientific,
Murrieta, CA) drilled out to an internal volume of 3 p.L was used as the first mixing
chamber of the exponential gradient elution system, and the inlet port of the
injection valve served as the second mixing chamber. A micro-injection valve with
a port-volume of about 10 j.iL (Rheodyne Model 8125, Rohnert Park, CA) was used
with a sample injection loop of 5 p.L for off-line nano-LC/UV runs and on-line
LC/MS runs. PEEK tubing with 60 p.m i.d. was used to connect the pumps to the
filter, splitter, mixing chamber, and injector. The inlet of the 75 mm i.d. x 20 cm
nanocolumn was attached directly into the injector's outlet port. The outlet of the
nanocolumn was connected via a 30 p.m i.d. x 20 cm fused-silica transfer line to a
capillary electrophoresis (CE) unit (Beckmann P/ACE System 2210, Fullerton, CA)
in order to provide UV detection and data acquisition capabilities for the system.
The nanocolumn was attached to the transfer capillary with a short piece of Teflon
tubing; the length of the transfer capillary from the outlet of the nanocolunm up to
the detector was 13 cm. A small diameter hole was drilled in the upper part the CE
unit's cartridge (the housing that holds the capillary in place) to allow the packed
capillary column to be connected to the transfer line inside the cartridge. A small73
hole, aligned with the hole in the cartridge, was also drilled in the upper right part
of the cartridge interface of the CE unit.
For LCIMS runs, the column was connected directly to the injector placed in a
plastic box, and the spraying voltage was applied directly to the injector after
loading the sample.
Samples were loaded from the injection valve onto the nanocolumn by connecting
pump A to the system and raising the inlet pressure to 200 bar so the sample was
displaced from the injection ioop by solvent A onto the column at a flow rate of
1.2 pL/min. After allowing sufficient time to completely displace the sample from
the injection loop (1O mm), pump A was stopped and, after allowing the pressure
to drop to 1 bar, disconnected from the system. Pump B was then connected to the
system, and the inlet pressure was raised to 100 bar to deliver solvent B at 0.5
pL/min.
3.2.8. Mass Spectrometry
MALDI-TOF MS analyses were perfonned on a custom built instrument [1]
equipped with delayed extraction and an ion mirror. The MALDI probe was spotted
with 1 pL of a 1:3 (v:v) mixture of nucleopeptide sample (0.5 iL) and a saturated
solution of 2,4,6- trihydroxyacetophenone (THAP) (Sigma, St. Louis, MO) in 50 %
acetonitrile). The instrument was operated in the positive ion mode with an74
accelerating potential of 20 kV and an extraction delay of 500 ns. A spectrum was
producedbyusingMoverZsoftware(ProteoMetrics,LLC,http://www.
proteornetrics. corn /software/rnz. htm) to collect and average data generated from 30
laser pulses.
On-line nano-LC ESI MS runs were performed on an LC-Q ion trap (Finnigan, San
Jose, CA) mass spectrometer. The LC-Q was operated in the MS-mode with the
spraying potential set to 2.5 kV (applied to the injector), the temperature of the
heated inlet-capillary at 180 °C, the capillary potential at 46 V, the tube-lens offset-
potential at 30 V, and a maximum injection time of 50 ms. For operation in the
MS/MS-mode, the maximum injection time was increased to 500 ms, the isolation
width was set to 1 Da, and the collision energy was set to 30 %. MS/MS spectra
were recorded only for the doubly charged molecular ions of nucleopeptides.
3.3. RESULTS
3.3.1. MALDI Spectra of Nucleopeptides
A preparative crosslinking reaction mixture containing Ung and dT20 (13 molar
ratio) was UV irradiated and separated by 12.5% SDS-PAGE. Two gel bands
corresponding to the free protein (25 kDa) and to the Ung x dT20 nucleoprotein
complex (-30 kDa) were revealed after copper staining[83]. The bands75
corresponding to the nucleoprotein complex were excised and in-gel digested with
trypsin. Crosslinked tryptic peptides (nucleopeptides) were separated from non-
crosslinked peptides using a procedure based on anion exchange chromatography
developed in our lab. According to this procedure, peptides and nucleopeptides
produced from the in-gel digestion were extracted from gels using an organic
extraction mixture. This organic solution was concentrated to near dryness by
vacuum centrifugation. The sample was redissolved in a low ionic strength buffer
and loaded on a anion exchange column. Nucleopeptides were selectively retained
on this column while tryptic peptides were washed away. Finally, nucleopeptides
were eluted with a high ionic strength buffer, desalted, and concentrated. Samples
prepared in this manner are suitable for mass spectrometric analysis.
The MALDI spectrum of the purified mixture of Ungx dT20nucleopeptides
(Figure 3.1A) showed the presence of four ion species at m/z 7193, 7810, 7967 and
8102. The average molecular weight ofdT20(6024 Da) was subtracted from the
measured molecular weights resulting in the peptide masses of 1169 Da, 1786 Da,
1943 Da and 2078 Da. From previous work [11,12], these peptide masses are
known to correspond toT18(1169 Da),T18119(1786 Da),T11(1943) and*T6(2078,
T6minus the last 3 amino acids from the C-terminal). Based on this evidence, it
was concluded that the following peptide regions from Ung are involved in binding
DNA:T6(58-VVILGQDPYHGPGQAHGLAF-77),T11(130-AGQAHSHASL
GWETFTDK- 147) andT18(1 85-APHPSPLSAHR- 195).76
Previous crosslinking studies performed in our lab using poly-dT substrates
[3,11,12] indicated that nucleopeptide masses were very close to the sum of the
neutral oligonucleotide mass plus the neutral peptide mass. This finding is strong
evidence for the formation of "zero-length" covalent bonds between DNA and
proteins after low intensity UV-irradiation [17].
The nucleopeptide isolation procedure is essential in order to achieve reliable
information by MALDI MS. Specifically, the nucleopeptide sample must be free of
non-crosslinked peptides and DNA substrate. If both free peptides anddT20are
present, the MALDI process can form adducts between them, and these adducts can
be mistaken for nucleopeptides. The MALDI spectrum exhibited in Figure 3.1B
was produced after mixing a peptide fraction containingT17andT18with dT20. The
signals observed at m/z 6656 and m/z 7193 correspond to MALDI adducts
produced by the addition of a dT20 molecule to each peptide. These adducts are
artifacts of the MALDI ionization process and, as such, do not reflect the actual
composition of the sample. The spectrum also shows the signal corresponding to
the freeT18peptide (m/z 1169.6), but the signal corresponding to theT17peptide
(m/z 633) was obscured by the matrix ions normally present in MALDI spectra
below 700 Da. Clearly, it is not possible to distinguish between real nucleopeptides
present in the sample and MALDI artifacts unless the nucleopeptide sample is free
of peptides or free of dT20. Purification is the most challenging aspect in the
MALDI analysis of nucleopeptides.77
Figure 3.1. MALDI spectra of nucleopeptides. (A) Ung nucleopeptides were
purified from in-gel digestions of 30 bands corresponding to the Ung x dT20
nucleoprotein complex. An aliquot (1 tL) of the purified nucleopeptide sample was
mixed with THAP matrix in a 1:3 ratio and analyzed by MALDI MS.The
spectrum shows the presence of four nucleopeptides (m/z 7193, 7810, 7967, 8102).
(B) MALDI adducts produced by mixing Ung tryptic peptides with dT20 in a molar
ratio of about 1:10. Tryptic peptidesT17andT18were isolated in the same fraction
by preparative scale nano-LC and mixed with dT20. An aliquot (1 pL) of this
sample was analyzed as above by MALDI MS. The signal observed at m/z6656
corresponds to an adduct ofdT20with T17, while the signal at m/z 7193 corresponds
to an adduct ofdT20withT18.Intensity
7193 =T18xdT20
7810 =T18119xdT20
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Figure 3.1A. MALDI spectrum of Ung peptides crosslinked to dT20.
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Figure 3.1B. MALDI spectrum showing the adducts formed after mixing a fraction
containingT16andT18with dT20.3.3.2. Off-line Nano-LCIUV Followed by MALDI Analysis
Characterization of individual nucleopeptides was initially attempted by collecting
corresponding fractions of eluate from nano-LVIUV runs followed by MALDI and
nanospray analysis. The utility of peptide fractionation by nano-LC before MALDI
or nano-ESI has been previously demonstrated [53]. A nucleopeptide sample was
digested with nuclease P1, and the sample was injected into the nano-LC system.
The nano-LC/LTV chromatogram obtained is exhibited in Figure 3.2. The sensitivity
is not as great as would be obtained with a conventional UV-detector because a
very short path length (30 rim) is used for the nano-LC system. The baseline
absorbance in this chromatogram gradually decreases with increasing time as
acetonitrile from solvent B (40 % acetonitrile with 0.1 % TFA) replaces water from
solvent A (0.1 % TFA in water). Two fractions with a volume of 3L each were
collected manually. Figure 3.3A shows the MALDI spectrum obtained for Fraction
1, while Figure 3.3B shows the MALDI spectrum obtained for Fraction 2. Fraction
1contained theT18peptidecrosslinkedto two (MW1796.4) orthree
(MW=2 100.8) deoxythymidine bases and, Fraction 2 revealed a*T6
(5)peptide
fragment(*T6(5)isT6without the last five C-terminal amino acids) crosslinked to
two thymidine bases (MW=2486.4).1
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Figure 3.2. Nano-LCIUV chromatogram produced by loading the column with 10 L of a
nuclease P1 digest. The sample was eluted at 0.5 tL/min (pressure at inline filter100 bar)
with an exponentially produced gradient of 0% to100% solvent B (0.1 % TFA in 40%
acetonitrile). UV detection was at 200 nm. Two fractions were collected manually with a fraction
volume of 2 p.L (2 mm collection period). One p.L of Solvent A (0.1% TFA in water) was added
to each vial before starting the manual collection.
QO82
Figure 3.3. MALDI spectra ofdT2..3isolated nucleopeptides. (A) MALDI
spectrum ofT18xdT2(m/z 1796.4) andT18xdT3(m/z 2100.8) nucleopeptides
isolated in Fraction 1. The inset picture shows the isotopic distribution ofT18xdT2.
(B) MALDI spectrum of*T6
(5)xdT2nucleopeptide isolated in Fraction 2. An
aliquot (1 .iL) of the purified nucleopeptide sample was mixed with THAP matrix
in a 1:3 ratio and analyzed by MALDI MS.12
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Figure 3.3A. MALDI spectrum of Fraction 1.
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Figure 3.3B. MALDI spectrum of Fraction 2.85
These results demonstrate clearly that some of the Ung amino acids involved in
binding DNA are located within theT6andT18tryptic peptides. However,
nanospray MS/MS analysis performed on the Fraction 1failed to provide the
sequence information needed to assign the locations of amino acids involved in
DNA interaction.
3.3.3. On-line Nano-LC/MS
In a second attempt to characterize individual nucleopeptides, an on-line nano-
LC/ESI-MS/MS approach was used in order increase sensitivity. To preserve the
chromatographic resolution provided by the nano-LC column and to avoid
additional dead volumes introduced by the coupling between the nanocolumn and
the spraying needle, a 40 cm long column was packed into a fused-silica capillary
with an integral frit. The spraying voltage (2.5 kV) was applied at the injector since
the tapered fused silica needle is not an electrically conducting material. Figure 3.4
shows the nano-LC/ESI-MS extracted ion chromatogram obtained for a nuclease
P1 digested nucleopeptide sample. The MS/MS spectra were recorded for the
doubly charged molecular ions ofT18, T11*T6(3) *T6(5)and*T6(7)nucleopeptides.
Three different nucleopeptide species derived from Ung peptideT6with 3, 5, or 7
aminoacids lost from the C-terminal were observed. The fragmentation patternsT6(5) xdT2
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Figure 3.4. Nano-LC/ESI-MS extracted ion-chromatogram of P1 digested nucleopeptides. For all peaks the doubly
charged molecular ions were selected. The inset picture shows the LCIMS chromatogram produced for theT18isomers. The
nucleopeptide sample (5L) was injected into the column (75 tm i.d. x 40 cm long; 5 pmC18)and eluted at 0.5 tL/min
(pressure at inlet filter = 140 bar) with an exponentially produced gradient of 0% to '- 100% solvent B (0.1% AA plus 0.01%
TFA in 40% acetonitrile). Ion detection was from mlz 300 to 2000.87
deduced from the MS/MS spectra of all threeT6derived peptides identified two
aminoacids (Y66 and H67) as being crosslinked, confirming the previous findings
for this peptide [11,12]. The MS/MS spectrum obtained for theT11x dT2
nucleopeptide failed to reveal a definite location for any crosslinked amino acid.
Unexpectedly clustered around an elution time previously found to correspond to
theT18x dT2 nucleopeptide, three different peaks were resolved in the LC/MS
chromatogram. These three peaks are displayed in the inset picture in Figure 3.4. It
was determined from the MS/MS spectra of these three compounds that they have
the same peptide backbone(Ti8peptide) but with dinucleotides attached to
different aminoacids. The tandem mass spectra of theseT18x dT2 isomers are
presented in Figure 3.5A-C. The fragmentation patterns observed in the case of
each isomer are summarized in the fragmentation diagrams displayed at the top of
each spectrum. There are a few common ions present in all three spectra: two of
them produced by the fragmentation of the dinucleotide "tag" (ai at m/z 737.4 and
c1at m/z 777.4); two others produced by fragmentation of the peptide backbone
at m/z 814.5 and [y9+Thyminef2 at m/z 564.4); and one other doubly charged
species (m/z 648.4) corresponding to theT18peptide crosslinked to thymine.
Crosslinked amino acids can be recognized from peptide backbone fragmentation
since some of the b and y ions will retain the dinucleotide "tag" (626.4). These ions
are labeled*bandin the spectra shown in Figure 3.5A-C. Based on the MS/MS
fragmentation pattern observed for the firstT18x dT2 isomer eluted off the column
(Figure 3.5A) it was concluded that either P188 or S189 is crosslinked.88
Figure 3.5. Tandem mass spectra ofT18xdT2nucleopeptide isomers apearing
in the insert shown in Figure 3.4. (A) MS/MS spectrum of the nucleopeptide
isomer corresponding to Peak 1 (B) MS/MS spectrum of the nucleopeptide isomer
corresponding to Peak 2; and (C) MS/MS spectrum of the nucleopeptide isomer
corresponding to Peak 3. The precursor selected for fragmentation (30% collision
energy) was the doubly charged molecular ion at 898.5 m/z. The fragmentation
patterns observed in the case of each isomer are summarized in the fragmentation
diagrams displayed at the top of each spectrum.+2
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Figure 3.5A. MS/MS spectrum of theT18xdT2nucleopeptide isomer corresponding to Peak 1 from Figure 3.4.100
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Figure 3.5B. MS/MS spectrum of theT18x dT2 nucleopeptide isomer corresponding to Peak 2 from Figure 3.4.1
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Figure 3.SC. MS/MS spectrum of the T18 x dT2 nucleopeptide isomer corresponding to Peak 3 from Figure 3.4.92
In the case of the second nucleopeptide isomer (Peak 2), the crosslinked amino acid
was unambiguously identified as 11187 based on the presence of three intense ions:
*+2*+ +
y9,b3 andy8observed in its spectrum (Figure 3.5B). The fragmentation
pattern observed for the lastT18x dT2 isomer (Peak 3) indicates that at least one
aminoacid from the sequence 192-SAH-194 is crosslinked (see Figure 3.5C).
3.4. DISCUSSION
The ultimate outcome of using mass spectrometry to characterize peptide-nucleic
acid complexes is the identification of specific amino acids that are crosslinked to
the oligonucleotide. In pursuing this objective, tandem mass spectrometry was used
to investigate the fragmentation patterns of dinucleopeptides isolated from the
{ Ung x dT2o} nucleoprotein complex. Dinucleopeptides were produced by
nucleolytic digestion of a nucleopeptide sample isolated according to a three step
purification protocol developed in the authors' laboratory. As previously reported
[7,11,12], steric interference between the peptide portion of the nucleopeptide and
the nuclease prevents nucleolysis from proceeding to the mononucleotide level.
Two nucleopetides were identified by off line nano-LC MALDI-TOF approach
shown in Figure 3.2 and seven dinucleopetides were identified by online nano-LC/ESI-MS/MS. The nanospray MS/MS spectrum obtained for Fraction I (data not
shown) contained contradictory information regarding the fragmentation pattern of
T18x dT2. Subsequently, on-line nano-LC/ESI-MS (Figure 3.4) clearly revealed
thatT18x dT2 comprised three, barely resolvable isomers. This finding made it
immediately clear that it would have been impossible to distinguish the individual
fragmentation pattern of any of these isomers from the other two in the spectrum of
Fraction1becauseallthree were presentinthisoff-linefraction.The
chromatographic separation of theT18x dT2 isomers thus was decisive in resolving
the nature of the photochemical crosslinking to dT20 that occurs in the DNA-
binding domain of Ung. The MS/MS spectra of the three isomers have some
common features that are easily attributable to the fragmentation of the dT2tag
that each possesses. As has been previously observed [10-12], collision induced
fragmentation along the backbone of the peptide portion of a nucleopeptide is
usually weak. Nonetheless, the information obtained from these spectra of the three
T18x dT2 isomers was sufficient to unambiguously show that at least three amino
acids inT18are crosslinked to a dT2. This new finding suggests that the mass
spectrometric protocol used to obtain it is capable of revealing biologically relevant
information about DNA-binding domains in proteins.
Definitive identification of Hi 87 as one of the crosslinked amino acids (Figure
3.5B) is in good agreement with previous information obtained using site-directed
mutagenesis[84],crystallography[77,79]and NMR spectroscopy[79,85].
Specifically, Ung exhibited a 55,000-fold lower specific activity and a shift in pHoptimum from 8.0 to 7.0 when H187 was mutated into aspartic acid [84].
Surprisingly, Hi 87 is not involved in a stacking interaction with the uracil base as
are most aromatic amino acids. NMR spectroscopy [79,85] showed the formation
of a short hydrogen bond between Hi 87 and an oxygen atom from uracil. It seems
plausible that a similar interaction could occur between Hi 87 and one of the
thymidines fromdT20.
Furthermore, Si 89 is known to be involved in DNA interactions with the phosphate
backbone [82]. Although the fragmentation data obtained from the spectrum shown
in Figure 3 .5A indicated that either P i 88 or Si 89 will sometimes crosslink to dT20
under UV irradiation, photochemical crossslinking studies conducted by others
indicate that a serine is more likely to be involved in crosslinking than a proline
[i 7].
It can only be deduced from the fragmentation pattern exhibited in Figure 3.5C that
at least one of the three residues in the sequence 1 92-SAH- 194 forms covalent
bonds to dT20 during the photochemical crosslinking experiment. The known nature
of chemical interactions between proteins and nucleic acids and the fact that H 194
is the only aromatic aminoacid in this group of residues, suggests that Hi94, rather
than S192 or Ai93 is the residue in the thirdT18xdT2isomer (Peak 3, Figure 3.4)
that crosslinks todT20.
TJV photocrosslinking can only reveal amino acid interactions with the nucleobases
that make up a DNA substrate; electrostatic interactions with the phosphate
backbone cannot be observed via this technique. Thus, base stackings between95
aromatic amino acids and nucleobases are the most likely form of protein-nucleic
acid interaction to be observed in a UV crosslinking experiment. The mass
spectrometric data obtained fromT6in this study as well as an earlier study [11,121
are consistent with these mechanisms. Specifically, base stacking interactions were
observed in theT6peptide for Y66 and H67, but the electrostatic interaction
between D64 and the phosphate backbone was not observed despite the fact that it
was previously reported in several X-ray diffraction papers [75,77]. Given that the
thirdT18x dT2 isomer is the most intense peak in the inset of the LC/MS
chromatogram from Figure 3.4 and that the aromatic H194 is the only residue on
the C-terminal of Ti 8 that can participate in a base stacking interaction with dT2O,
it is very probable that H194 is thedT2tagged residue in this nucleopeptide
All of the information regarding the DNA-binding domain of Ung obtained from
this study by UV crosslinking and mass spectrometry is summarized in the 3D-
structure showed in Figure 3.6. This 3D-model corresponds to the crystal structure
of E.coli uracil-DNA glycosylase reported by Xiao et al [77]. Three peptide regions
involved in crosslinking (T6,T11and T18) are colored in blue, and five crosslinked
amino acids (Y66, H67, Hi87, S189 and H194) are colored in red. All these amino
acids belong to the DNA-binding domain of Ung, and their interactions with the
DNA substrate are consistent with the formation of a stable {Ung xdT2o}
nucleoprotein complex.SI 89
Figure 3.6. 3D structure of Ung showing the DNA-binding region of the protein
obtained from crystallography data [77]. Each of the three distinct peptide regions
colored in blue have at least one crosslinked amino acid. Several amino acids, along
with a serine residue, were identified by UV-photocrosslinking and mass
spectrometry as being crosslinked to oligonucleotide dT20. All crosslinked amino
acids are colored in red. The drawing was generated using the RasMol program [86].97
In addition to these five residues, the isolation of aT18x dT2 nucleopeptide in this
study and an earlier study [11,121 suggests there should be at least one other amino
acid (fromT1')interacting with the DNA substrate. More experiments will be
required to identify the crosslinked amino acids inT11.
The results of this study have demonstrated that chromatographic resolution of
nucleopeptide isomers coupled with tandem mass spectrometry enable in depth
structural analysis of a nucleoprotein complex.4. IDENTIFICATION OF AMINO ACID RESIDUES IN THE
SINGLE-STRANDED DNA BINDING DOMAIN OF HUMAN
REPLICATION PROTEIN A
Reproduced with permission from Doneanu, C.E., Gafken, P.R., Bennett, S.E., and
Barofsky, D.F,I Biol. Chem.,submitted.
4.1. INTRODUCTION
Protein-nucleic acid interactions are involved in many cellular processes including
transcription, translation, replication, recombination and genomic damage repair.
Mass spectrometry in combination with photochemical/chemical crosslinking,
along with X-ray diffraction and NMR spectroscopy, is considered to be a method
that provides information directly about the structural relationship between proteins
and nucleic acids. The strategy, which combines low intensity UV crosslinking and
mass spectrometry, was initially demonstrated in 1994 [3]. Subsequently, laser-
induced crosslinking[4,5] and chemical crosslinking [6] have been used in
combination with mass spectrometry to investigate protein-DNA interactions. The
coupling of photocrosslinking to mass spectrometry for protein-DNA analysis has
seen more frequent usage of late [7-14,107].
Photochemically crosslinking nucleic acid binding proteins to their substrates is an
established procedure for characterizing protein-nucleic acid interfaces [17-19].This technique exploits photons to induce the formation of "zero-length" covalent
bonds between certain amino acids that are in close contact with nucleic acid bases
[17]. It is assumed that only amino acids located in the protein's binding site are
involved in the formation of these bonds. For mass spectrometric identification of
amino acids that take part in the crosslinking, a general methodology has evolved.
This methodology uses enzymatic digestion of the UV-irradiated nucleoprotein
complex to produce free peptides and peptides crosslinked to the nucleic acid
substrates (nucleopeptides). After separation from the non-crosslinked peptides, the
nucleopeptides are analyzed by MALDI-TOF to determine their molecular weights.
By comparing the mass of a nucleopeptide minus the mass of the attached
oligonucleotide to a peptide map of the native protein, one can identify regions
comprising peptides that are involved in crosslinking. This straightforward strategy
can be used only if the chemistry of the photochemical reaction is known. Finally,
the nucleopeptides are sequenced by tandem mass spectrometry (MS/MS) in order
to identify the particular amino acids attached to nucleic acid bases. In a few
instances, a combination of exhaustive enzymatic digestion and MALDI-TOF MS
can provide enough information to locate the crosslinked amino acids within a
nucleopeptide [8].
In this paper, we report the use of photochemical crosslinking and mass
spectrometry to investigate the DNA-binding domain of human Replication Protein
A (hRPA). hRPA is a heterotrimeric single-stranded DNA-binding protein that is
required for multiple processes in cellular DNA metabolism, including DNA100
replication, repair, and recombination [87]. This protein was originally purified
from human cell extracts and identified as a protein required for simian virus 40
(SV4O) DNA replication [88,89]. Analysis of hRPA indicated that it is a stable
complex of three subunits with molecular masses of 70, 32 and 14 kDa (hRPA7O,
hRPA32, and hRPA14, respectively) [55,90]. The protein binds single-stranded
DNA (ssDNA) with specific polarity [91] and high affinity. It forms a stable
complex with DNA that has an occluded binding site size of 30 nucleotides [92,93],
although two other binding modes involving 8-10 nucleotides and 13-14
nucleotides were reported [94,95]. Deletion and mutational analyses [87,96] have
identified four domains in hRPA7O: an N-terminal domain (residues 1-168) that
participates in hRPA-protein interactions, a central DNA binding domain (residues
169-44 1), a putative zinc-finger motif (residues 48 1-503), and a C-terminal domain
(residues 503-616). Recent data [97,98] indicate that the C-terminal domain of
1IRPA7O is also a DNA binding domain (domain C).
The structure of the central DNA-binding domain has been previously investigated
by X-ray diffraction [56,99] and site-directed mutagenesis [98,100]. The crystal
structurerevealed a central DNA-binding domain comprising two,three-
dimensionally identical copies of a single-stranded DNA binding subdomain. These
subdomains (identified as A and B) resemble an OB-fold motif that has been
previously found in various oligonucleotide/oligosaccharide-binding proteins [101].
Subdomains A (residues 18 1-290) and B (residues 300-426) are oriented in tandem,
and a DNA binding channel extends from one subdomain to the other. Each101
subdomain is in direct contact with three nucleotides while two nucleotides fill the
space between the subdomains. Two primary types of interaction were observed to
occur between the protein and DNA: stacking interactions between several
aromatic aminoacids (F238, F269, W361 and F386) and individual nucleic acid
bases, and hydrogen bonding between amino acid side chains and either the
phosphate backbone or individual nucleic acid bases. The X-ray data does not make
clear what the individual contributions of these interactions to the overall DNA-
binding affinity of hRPA. Furthermore, the importance of aromatic amino acids
interacting with single-stranded DNA has been questioned since site directed
mutants of hRPA7O, in which F238, F269, W361 and F386 were changed to
alanine, resulted in only slight changes in the protein's binding constant. A double
mutant, in which F238 and W361 were changed to alanine, resulted in a decrease of
the hRPA binding constant by 3 orders of magnitude [1001; however, the structural
identity of the double mutant was determined by proteolytic sensitivity experiments
to be disrupted. Structural perturbation makes it difficult to draw conclusions about
the double mutant's phenotype, but the results obtained with the single aromatic
residue mutants suggest that no single aromatic residue is critical for the formation
of the hRPA-DNA complex [100].
Very recent studies [102-104] suggest a dynamic mechanism for hRPA binding to
ss-DNA, involving all three domains from hRPA7O (A, B and C) anda fourth
domain from hRPA32 (residues 43-171). This mechanism explains different
binding modes observed for hRPA.102
The present study focuses on the identification of some of the amino acid residues
located in the single-stranded DNA-binding domain of hRPA that are critical for
the formation of a stable protein-DNA complex.
4.2. EXPERIMENTAL
4.2.1. Chemicals
Acetic acid (AA), trifluoroacetic acid (TFA), ampicillin, bromophenol blue,
calcium chloride, copper (II) chloride, chloramphenicol, ethylenediaminetetraacetic
acid(EDTA),ferricchloridehexahydrate,formaldehyde,formicacid,
iodoacetamide, inositol, leupeptin, HEPES, Nonidet P-40, phenylmethylsulfonyl
fluoride (PMSF), potassium ferricyanide, sodium chloride, sodium thiocyanate and
Trizma (Tris-base), and 2,4,6-trixydroxyacetophenone (THAP) were purchased
from Sigma Chemical Co. (St Louis, MO). Acrylamide (>99% pure), ammonium
persulfate, Coomassie Brilliant Blue G-250, 2-mercaptoethanol, bis N,N' -methyl-
bis-acrylamide,andN,N,N'N' -tetramethyl-ethylenediamine(TEMED) were
obtained from Bio-Rad (Hercules, CA). Ammonium sulfate, dithiothreitol (DTT),
glycine, isopropy1-f-ö-thiogalactopyranoside (IPTG), and sodium dodecyl sulfate
(SDS) were acquired from Life Technologies Inc. (Grand Island, NY). HPLC grade
acetonitrile, ammonium acetate, ammonium bicarbonate, ammonium hydroxide103
(50%), glucose, hydrochloric acid, isopropanol, methanol, potassium chloride,
sodium carbonate, sodium hydroxide, sodium nitrate and sodium thiosulfate were
bought from Fisher Scientific (Pittsburgh, PA). Glycerol and potassium phosphate
(dibasic and monobasic salts) were purchased from J.T. Baker (Phillipsburg, NJ).
Agar, tryptone and yeast extract were supplied by Becton Dickinson (Franklin
Lakes, NJ). Water was generated with a Milli-Q water purification system
(Millipore Corp., Bedford, MA). Oligodeoxythymidine dT30, was synthesized by
the Biopolymer Core Facility, at the University of Maryland at Baltimore and
further purified on a 15% native polyacrylamide gel.
4.2.2. Protein Expression and Purification
Recombinant hRPA protein was expressed in E.coli cells by using the T7
expression system [105]. The plasmid plld-tRPA [106], along with the plasmid
pRIL (Stratagene, La Jolla, CA), were electroporated into E. coli strain BL21(DE3)
and plated on LB plates (1% tryptone, 0.5% yeast extract, 1% NaC1, 1.5% agar)
containing 1% glucose, 100 jig/ml ampicillin, and 34 1g!m1 chloramphenicol. A
single recombinant colony was selected to inoculate one liter of TB medium (1.25
tryptone, 2.4% yeast extract, 0.4% (w/v) glycerol, 0.017 M KFI2PO4, and 0.07 M
K2HPO4)containing1% glucose,100tg/mlampicillin,and 34tg/ml
chloramphenicol. The culture was incubated overnight at 30 °C without shaking104
and then placed on an orbital shaker and shaken at 37 °C. When the absorbance at
600 nm was between 0.6 and 0.8, the culture was induced by adding IPTG to 0.3
mM. After 2 h of induction, the cells were harvested by centrifugation at 4,000xg
and frozen at -80 °C until used.
All purification steps were carried out at 4 °C. Frozen cells (from 1 L of culture)
were resuspended in 50 mL of HI buffer (30 mM HEPES (pH 7.8), 1 mM DTT,
0.25 mM EDTA, 0.25% (w/v) inositol and 0.01% (v/v) Nonidet P-40) containing
50 mM KC1, 1 mM PMSF, and 0.1 tg/ml leupeptin. The cells were disrupted by
sonication, and the resulting lysate was cleared by centriftigation at 30,000xg for
30 mm. Soluble protein was applied to a 20-mL Affi-Gel Blue Gel column (12cm
x1.77 cm2, BioRad) equilibrated in HI buffer containing 50 mM KC1. The colunm
was washed sequentially with 3 column volumes each of HI buffer containing
respectively 0.05 M KC1, 0.8 M KC1, 0.5 M NaSCN, 1.0 M NaSCN, and 1.5 M
NaSCN. The peak of elution (represented by those fractions thatwere enriched for
the 70 kDa, 32 kDa, and 14 kDa subunits of hRPA)was determined by denaturing
polyacrylamide gelelectrophoresis and visualizing the protein bands with
Coomassie stain.Fractions containing the elution peak (present in the column
washings with HI buffer containing 1.5 M NaSCN)were pooled into 12,000-
14,000 molecular weight cutoff dialysis tubing (SpectraPor) and dialyzed against
HI buffer containing 500 mM NaC1.It is important to note that dialysis into HI
buffer containing 250 mM NaC1 resulted in extensive protein precipitation. After 6
h, the dialysis solution was replaced with fresh buffer and dialysiswas continued105
for an additional 14 h. The dialyzed sample was loaded onto a 23-mL single-
stranded DNA agarose column (4.5 cmx4.91 cm2) equilibrated in HI buffer
containing 500 mM NaC1. The column was washed with 3 column volumes of HI
equilibration buffer and then eluted with a 1 00-mL linear gradient of equilibration
buffer ranging from 500 mM NaC1 to 3 M NaC1. The peak of elution (present from
the 0.7 M to 1.7 M NaCJ region of the gradient), also monitored by denaturing
polyacrylamide gel electrophoresis, was pooled and concentrated by using a
Centriprep-30 cartridge (Millipore) and the buffer was exchanged to HI buffer
containing 200 mM KC1. Typically, about 1.0 mg of protein was obtained per liter
of cultured cells, and this material was estimated by densitometry experiments to be
greater than 90% pure hRPA (data not shown). Electrophoretic mobility shift
analysis of the purified protein, using [32P]dT3o as the DNA substrate, showed that
virtually all of the purified protein was capable of binding this substrate (data not
shown).
4.2.3. Photochemical Crosslinking Reaction
A 1:1 mixture of purified hRPA (800 pmol) anddT30(800 pmole) in HI buffer
containing 200 mM KC1 was placed in a 4 mL, capped quartz cuvette (NSG
Precision Cells, Farmingdale, NY) and equilibrated at room temperature for 30
mm. The cuvette was placed lengthwiseon a bed of ice and irradiated with UV106
light(?max=254 nm) for 1 mmin a Stratalinker 1800 crosslinker (Stratagene, La
Jolla, CA).
4.2.4. Isolation of Tryptic Peptides Crosslinked to dT30
Ten aliquots of the irradiated crosslinking mixture were loaded onto a 10% SDS
polyacrylamide gel and subjected to gel electrophoresis.After removing the
stacking gel, the lower 3-cm portion of the resolving gel corresponding to the
region of free dT30 was removed, and the remaining portion of gel was silver
stained [64]. Bands corresponding to hRPA7OxdT30 (XL-1 band) were cut from
the gel with a clean, sharp razorblade and placed into 1.5 mL Eppendorff tubes. Gel
slices were in-gel digested with trypsin (36 ngluL) following the procedure of
Shevchenko et al. [64]. After 2 h of digestion at 37 °C, 400 jtL of digestion buffer
was added to the gel slices, and digestion was continued overnight. Upon
completion of digestion, the aqueous solution was removed and saved. An organic
extraction mixture of FAPH (50% formic acid, 25% acetonitrile, 15% isopropyl
alcohol, and 10% water) was added to each tube until the gel pieces were covered,
and the tubes were vortexed at room temperature for 4 h. The extraction mixture
was removed from each tube and saved. Gel slices were then crushed and
dehydrated with 200 p.L of acetonitrile for 10 mm. The acetonitrile was removed,
with care not to remove any gel pieces, and added to the saved FAPH extraction107
solutions. The combined organic solutions were concentrated to near dryness by
vacuum centrifugation. The saved aqueous digestion solution was adjusted to 10
mM Tris-HC1 (pH 7.2), 1 mM EDTA, and 100 mM sodium chloride (TE-100), and
the dried organic extraction fractions were resuspended with 250 L TE-100. Both
the adjusted aqueous digestion solution and the resuspended organic extraction
solution were applied to a NAC-52 anion exchange cartridge (Life Technologies
Inc.) that had been activated with 3 mL TE-2000 (TE buffer containing 2000 mM
sodium chloride) and equilibrated with 5 mL TE-100. After sample loading, the
cartridge was washed with 5 mL TE-100 and the peptidex dT30fragments
(nucleopeptides) were eluted with 1 mL TE- 1000 directly into a Centricon-3
(Millipore) desalting cartridge. The Centricon-3 was centrifuged at 6000Xg. The
eluate was desalted by washing the Centricon-3 sequentially with 4.5 mL of water,
4.5 mL of 10 mM ammonium acetate, and 3 mL of water. The washed sample was
concentrated to 200 jtL, after which, it was transferred to a 750-jiL Eppendorff tube
and further concentrated to about 10 tL by vacuum centrifugation.
4.2.5. Nuclease P1 Digestion
Nuclease P1 (ICN Pharmaceuticals, Costa Mesa, CA)was diluted with 50 mM
ammonium acetate pH=6.5 (0.04 activity units/pL). After mixing 1 pL of nuclease108
P1 solution with 1tL of nucleopeptide sample, digestion was allowed to proceed
for4hat37°C.
4.2.6. Carboxypeptidase Y Digestion
Carboxypeptidase Y (Sigma) was diluted with 25 mM ammonium acetate pH=6
(0.5 activity units/tL). Extensive digestion was conducted for 48 h at 37 °C after
mixing 1 pL of CPY solution with 1tL of nucleopeptide sample.
4.2.7. ZipTip Clean-up of Digests
The nucleopeptide samples were cleaned up onC18ZipTips (Millipore) following
the manufacturer's directions for peptides. Metal chelate ZipTips (Millipore) were
used to clean-up a CPY digested nucleopeptide sample before recording its MALDI
spectrum. Briefly, 4 p1 of 0.1% AA were added to 1 p1 of nucleopeptide sample.
The ZipTip was preconditioned twice with 10 pL of 0.1% TFA in 50% acetonitrile,
then rinsed 10 times with 10 p.L of 200 mM ferric chloride hexahydrate in 10 mM
HC1, 10 pL of water (Millipore) and 10 p.L of 1% AA in 10% acetonitrile. The
sample was loaded on the tip by pipetting the solution 20 times in and out of the109
tip. The tip was also rinsed 5 times with 10 p.L of 0.1% AA in 50% acetonitrile and
10 pL of water. Nucleopetides were eluted with 1tL of 2% ammonium hydroxide.
4.2.8. Nano-LC Column Preparation
For on-line nano-LC/ESI MS, a fused-silica colunm with an integral frit-
"PicoFrit (360 pm o.d. x 75 jim i.d. x 40 cm, 15 jim tip) obtained from New
Objective (Cambridge, MA) was packed using the pressurized bomb method
described by Kennedy and Jorgensen [60]. Briefly, a 40 cm long "PicoFrit" colunm
was packed with 5tm, 300 A pore, LunaC18silica gel particles (Phenomenex,
Torrance, CA). The packing material suspended in isopropanol (25 mg!mL) was
forced into the capillary by pressurizing the bomb to 1,500 psi (about 6 hours are
required to pack a 40 cm long colunm). After the gas pressure was slowly released
from the bomb, the inlet of the column was connected to an HPLC pump and
flushed with acetonjtrile for 4 hours and Milli-Q water for another 4 hours.
4.2.9. Nano-LC Solvent Delivery System
The nano-LC system employed uses an exponential dilution method to produce
gradient separations. A detailed description of the system's operating principle and110
setup is provided elsewhere [53]. Briefly, elution gradients are produced by
exponential dilution in two mixing chambers. Two conventional HPLC pumps
(Kratos Analytical Spectroflow 400, Ramsey, NJ) were used, one to deliver solvent
A (0.1 % AA plus 0.01 % TFA) and the other to deliver solvent B (0.1 % AA plus
0.01 % TFA in 50% acetonitrile). From the pump, solvent is passed through an
inline filter (Kratos Analytical, Ramsey, NJ) into a flow-splitter. The filter helps
avoid clogging of the system downstream. The flow-splitter comprises a PEEK Y-
piece (Valco, Houston, TX), a 30 tm i.d x 50 cm fused-silica waste-line that
functions as a flow resistor, and a 60 jim i.d x 5 cm PEEK connecting line to the
first mixing chamber. The split-ratio of this arrangement is between 1:50 and 1:100
so the flow through the analytical column is in the range 300-800 nL/min. A ZDV
PEEK union (Upchurch Scientific, Murrieta, CA) drilled out to an internal volume
of 3 jiL was used as the first mixing chamber of the exponential gradient elution
system, and the inlet port of the injection valve served as the second mixing
chamber. A micro-injection valve with a port-volume of about 10 jiL (Rheodyne
Model 8125, Rolmert Park, CA) and a sample injection loop of 5 jiL was used.
PEEK tubing with 60 jim i.d. was used to comiect the pumps to the filter, splitter,
mixing chamber, and injector. The nano-LC column was connected directly to the
injector, which was placed in a plastic box, and the spraying voltage (2.5 kV) was
applied directly to the injector after loading the sample since the fused silica needle
was not electrically conductive.111
Samples were loaded from the injection valve onto the nanocolumn by connecting
pump A to the system and raising the inlet pressure to 200 bar so the sample was
displaced from the injection loop by solvent A onto the column at a flow rate of
0.8 tL/min. After allowing sufficient time to completely displace the sample from
the injection loop (1 5 mm), pump A was stopped and, after allowing the pressure
to drop to 1 bar, disconnected from the system. Pump B was then connected to the
system, and the inlet pressure was raised to 120 bar to deliver solvent B at 0.3
pt/mm.
4.2.10. Mass Spectrometry
MALDI-TOF MS analyses were performed on a custom built instrument [1]
equipped with delayed extraction and an ion mirror. The MALDI probe was spotted
with 1 p.L of a 1:3 (v/v) mixture of sample and a saturated solution of THAP in
50% acetonitrile. The instrument was operated in the positive ion mode with an
accelerating potential of 20 kV and an extraction delay of 500 ns. A spectrum was
produced by using MoverZ software to collect and average data generated from 30
laser pulses (ProteoMetrics, LLC, http://www.proteometrics. corn/software. html).
On-line nano-LC ESI MS runs were performed on an LC-Q ion trap (Finnigan, San
Jose, CA) mass spectrometer. The LC-Q was operated in the MS-mode with the
spraying potential set to 2.5 kV (applied to the injector), the temperature of the112
heated inlet-capillary at 180 °C, the capillary potential at 46 V, the tube-lens offset-
potential at 30 V, and a maximum injection time of 50 ms. The instrument was set
to acquire a full MS scan between 400 and 2000 m/z followed by an MS/MS scan.
For operation in the MS/MS-mode, the maximum injection time was increased to
500 ms, the isolation width was set to 2 Da, and the relative collision energy was
set to 35 % with a 30-ms activation time. Using a data dependent algorithm, the
first most intense ion from a list of parent ions was selected for MS/MS providing
the ion's MS signal was higher than 2 xiO4counts.
4.3. RESULTS
Previousstudies employing a combination of photocrosslinking and mass
spectrometry to investigate protein-DNA interactions almost exclusively used
photoaffinity labeling either with low intensity UV-irradiation [8,10] or with laser-
inducedcrosslinking[6,7,107].Intheseearlyexperiments,photosensitive
nucleobase analogs (containing 5-bromouracil or 5-iodouracil in most cases) were
used instead of natural nucleobases in order to increase the crosslinking efficiency.
Typically, these analogs are irradiated at wavelengths longer than 300 nm, far
beyond the absorbance bands of nucleic acids and proteins, to decrease protein or
DNA photodegradation. In the opinion of the present authors, these non-natural
nucleobases canstructurallyperturbthenativenucleoprotein complex or113
photochemically bind to amino acids that are not biologically involved in DNA-
binding. For this reason, photoaffinity labeled DNA substrates were not used in this
work.
The size of thedT30substrate used in the present experiments was selected to
correspond to the reported size of hRPA's DNA-binding size [92,93], and its
polydeoxythymidinecompositionwaschosenbecausethethymine's
photocrosslinking reactivity is much greater than the other nucleic acid bases [17].
Several smallscaleelectrophoreticmobilityshiftassay experiments were
conducted in order to optimize the ratio ofdT30to hRPA needed to form a stable
protein-DNA complex (data not shown). Small scale UV-crosslinking experiments
were also performed tooptimize theirradiationtime. These crosslinking
experiments (data not shown) clearly indicated hRAP7O as the major subunit
involved in crosslinking to dT30, a finding in agreement with results obtained by
others [106].
Preparative scale crosslinking reactions were performed to obtain sufficient
quantities of crosslinked material for characterization of the oligonucleotide
binding domain of hRPA7O. Aliquots were removed from the crosslinking mixture
both before (Figure 4.1, Lane 1) and after UV-irradiation (Figure 4.1, Lane 2) and
analyzed by SDS-PAGE. The three bands present in the non-irradiated sample
(Lane 1) correspond respectively from top to bottom to hRPA7O,a proteolytic
fragment of hRPA7O, and hRPA32. No nucleoproteins were present in Lane 1
because the noncovalent complexes present in the reaction mixturewere disrupted114
by the denaturing conditions of SDS-PAGE. These three bands were also present
after UV-irradiation (Lane 2) along with the two new bands labeled XL- 1 and XL-
2. Given the appearance of these additional bands after UV-irradiation and the fact
that their position in the gel was more retarded than hRPA7O, these bands were
assumed to contain crosslinked nucleoprotein complexes involving hRPA7O. The
XL-1 band, at a position corresponding to a relative molecular weight of about 80
kDa, was thought to corresponds to a hRPA7O x dT30 nucleoprotein complex, while
the XL-2 band, at a position corresponding roughly to 90 kDa was presumed to
correspond to a ITIRPA x(dT3o)2nucleoprotein. This study focused only on the
analysis of the XL-1 band leaving the more difficult multinucleotide complex for
future study.
Observation of additional, higher molecular weight bands in Lane 2 of the gel
shown in Figure 4.1 seems to be a clear indication that photochemical crosslinking
produces stable complexes. The bands corresponding to XL-1 from all ten aliquots
of the preparative scale reaction mixture were cut out and individually subjected to
in-geldigestion with trypsin;the resulting ten digests were then pooled.
Crosslinked tryptic peptides (nucleopeptides) were separated from non-crosslinked
peptides using a procedure based on anion exchange chromatography developed in
the authors' laboratory (see Experimental section). MALDI mass spectra of
samples prepared in this manner consistently showed seven prominent ion species.
A typical spectrum is shown in Figure 4.2.S.,
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Figure 4.2. MALDI spectrum of hRPA7O peptides crosslinked to dT30. The mass
spectrum was produced from a pooled sample of purified in-gel digests of ten bands
corresponding to an 80 kDa crosslink (XL-1 in Figure 4.1). An aliquot (1L) of the
purified nucleopeptide sample was mixed with THAP matrix in a 1:3 ratio for the
MALDI analysis. The spectrum shows the presence of both crosslinked (m/z 9082,
10184, 10691) and non-crosslinked hRPA7O peptides (m/z 737.4, 1119.6, 1626.8).117
Subtractingtheaverage molecular weight of dT30(9064 Da) from the
experimentally determined molecular weights of the three putative nucleopeptides
evident in Figure 4.2 yields the masses of 738 Da, 1120 Da, and 1627 Da for the
three corresponding protonated peptides. Ion signals corresponding to non-
crosslinked peptides are also present in the nucleopeptide spectrum at m/z values of
737.4, 1119.6, and 1626.8.
The nucleopeptide sample was digested with nuclease P1 in order to reduce the
oligonucleotide portion of the molecules, MALDI MS characterization of the
nuclease digestion products (Figure 4.3) revealed three nucleopeptides (m/z 1363.8,
1746.0, and 2253.2) and the same free peptide (m/z 1626.8) observed in the
MALDI mass spectrum from Figure 4.2. Subtracting the average molecular weight
ofdT2(626.4) from the signals observed at m/z 1363.8, 1746.0, and 2253.2 resulted
in the molecular weights of 737.4 Da, 1119.6 Da and 1626.8 Da, for the
corresponding protonated peptides, respectively. These same peptide masses were
identified from the MALDI mass spectrum of the nucleopeptides prior to nuclease
digestion (Figure 4.2).
The sample digested with nuclease P1 was analyzed on a nanoscale liquid
chromatography electrospray ionization mass spectrometry (nanoLC-ESI/MS)
system, specially constructed to preserve the chromatographic resolution provided
by the nano-LC colunm and to avoid the additional dead volumes that usually
accompany the coupling between a nanocolumn and the spraying needle.I,'
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Figure 4.3. MALDI spectrum of hRPA7O nucleopeptides digested with nuclease
P1. The mass spectrum was produced from a nuclease P1 digest of the purified
nucleopeptide mixture whose MALDI spectrum is displayed in Figure 4.2. An aliquot
(1 .tL) of the P1-digested sample was mixed with THAP matrix in a 1:3 ratio for the
MALDI analysis. Three of the observed signals correspond to products of the
nucleolytic digestion of nucleopeptides (m/z 1363.8, 1746.0, and 2253.2). The signal
at m/z 1626.8 is due to a non-crosslinked peptide.
00119
The reconstructed ion chromatogram displayed in Figure 4.4 indicates the presence
of three free peptides in the nuclease P1 digest.
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Figure 4.4. Nano-LCIESI-MS reconstructed ion chromatogram of the nuclease
P1 digest. A portion (2 uL) of nuclease P1 digested sample (Figure 4.3) was mixed
with solvent A (4 uL), injected onto the 40 cm nano-LC column, and analyzed by
nanoLC/ESI-MS. Ions were detected from m/z 400 to 2000. The chromatogram
was reconstructed from the doubly protonated molecular ion signals produced by
the three peptides found in the MALDI spectrum from Figure 4.2. The tryptic
peptides are labeled starting from the N-terminus of 1IRPA7O.
The ESI MS/MS spectra obtained from the peptides that give rise to the three
chromatographic peaks seen in Figure 4.4 are displayed in Figure 4.5A-C.120
Figure 4.5. MS/MS spectra of the hRPA7O tryptic peptides corresponding to
the chromatographic peaks seen in the ion chromatogram of the nuclease P1
digest (Figure 4.4). Tandem mass spectra were obtained for the (A) singly charged
ion at m/z 737.4, (B) the doubly charged ion at m/z 560.4, and (C) the doubly
charged ion at m/z 813.9. The sequence information provided by these mass spectra
revealed these peptides respectively to beT43, T28129and124/25minus its five C-
terminal residues.+
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Figure 4.5A. MS/MS spectrum of m/z 737.4.80
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Figure 4.5C. MS/MS spectrum of mit 813.9.124
ESI-MS/MS was attempted on the nucleopeptides present in the nuclease P1 digest,
but data could only be obtained for the nucleopeptideT28129 x dT2(m/z 1746.0),
even though this nucleopeptide produced the weakest signal of the three
nucleopeptides observed in the MALDI spectrum of the tryptic digest (Figure 4.3).
The nanoLC ESI-MSIMS spectrum of doubly protonatedT28129 xdT (Figure 4.6)
shown that the peptides's backbone fragments mainly into b-ions and thattwo of
these ions(*bsand*b9)have a dinucleotide tag (626.4 Da) attached to them.
The hRPA nucleopeptide samplewas extensively digested with Carboxypeptidase
Y (CPY) for 48 h then cleaned-up by immobilized metal affinity chromatography
(IMAC).
The MALDI spectrum of this CPY digest is exhibited in Figure 4.7. Thetwo
strongest signals in the range m/z 9,00012,000 of this spectrum correspond to
free dT30 (m/z 9065) and T43 x dT30 (m/z 9802). Five other weaker signals in this
envelope of ions presumably correspond to C-terminal truncated nucleopeptides.
Prior to CPY digestion (Figure 4.2), several signalswere observed in the low-mass
region (m/z 500-2000), butno signals were observed in this region after CPY
digestion.It is presumed that the free *T T28129and T43 peptides were
completely digested by CPY.100 Relative
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Figure 4.6. MS/MS spectrum of the tryptic peptide T289 crosslinked to dT2
nucleotide (T289 x dT2). The doubly protonated ion (m/z 873.4) was fragmented.
The fragmentation pattern observed for this nucleopeptide is summarized in the
sequence shown in the inset. The b ions labeled as b ions have a dinucleotide tag
(626.4 Da) attached.
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Figure 4.7. MALDI mass spectrum of a CPY digested nucleopeptide sample. 1 iL of
digested sample was mixed with 3 j.iL of THAP matrix solution and analyzed. The
signals observed at m/z 9532, 9717, 9886, 9950 and 10334 were assigned to several C-
terminal truncated nucleopeptides (see Table 4.1 for identification).127
4.4. DISCUSSION
The information contained in the MALDI mass spectra shown in Figure 4.2 and 4.3
was sufficient to tentatively identify two of the three putatively crosslinked
peptides of hRPA7O. The ion signal at m/z 737.4 is consistent with theT43tryptic
peptide (383-VSDFGGR-389), and the ion signal at m/z 1119.6 corresponds to the
tryptic fragmentT28129(264-IANKQFTAVK-273), which contains a missed
cleavage site. No hRPA tryptic peptide's mass matches the m/z value 1626.8 that is
prominent in Figures 4.2 and 4.3.
The appearance of signals corresponding to noncrosslinked peptides in the MALDI
spectra in Figures 4.2 and 4.3 suggests that nucleopeptide decomposition might
have taken place. This possibility is further indicated by the observation of a weak
signal corresponding to freedT30in the spectrum from Figure 4.2.
Sequence data obtained from the MS/MS spectra of the peptides that appear at 22.1
mmand 22.6 mmin the ion chromatogram (Figure 4.5A-B) confirmed the
identities ofT43andT28129that were tentatively made from the MALDI mass
spectrum from Figure 4.2. The ESI mass spectrum of the species appearing at 21.4
mm in the ion chromatogram (data not shown) exhibited a protonated ion signal at
m/z 1626.8, which almost exactly equals the m/z value determined for one of the
peptides that shows up in the MALDI mass spectra in a putative crosslinked form
(m/z 10,691, Figure 4.2) and a noncrosslinked form (Figure 4.2 and 4.3). None of
the predicted tryptic peptides of hRPA7O correspond to a protonated mass of128
1626.8; however, the data in the ESI MS/MS spectrum of the doubly protonated
form of the unknown peptide (Figure 4.5C) is conform to the sequence 235-
ATAFNEQVDKFFPL-248, which is that of the tryptic peptide T24125 minus its last
five C-terminal amino acids(*T24/25).
The appearance of ion signals corresponding to free peptides in the MALDI mass
spectra of the nucleopeptide sample (Figure 4.2), the MALDI spectrum of the
nuclease P1 digest (Figure 4.3), and in the nanoLC/ESI mass spectra of the
nuclease P1 digest (Figure 4.4) implies an inherent instability in the bands formed
by UV-crosslinking. Whatever its cause, this instability reduces the nucleopeptide
concentration. On the one hand, this adds to the difficulty of performing tandem
mass spectrometry on the nucleopeptides themselves, but on the other hand it
simplifies identification of the peptide components of the nucleopeptides.
MS/MS data could not be obtained for theT43x dT2 and the*Tx dT2
conjugates, but MS/MS data from T28129 x dT2 was forthcoming. The appearance of
b4 and b5 fragments in the latter's MS/MS spectrum (Figure 4.6) indicated that no
dT2 is attached to the N-terminal segment 264-IANKQ-268 whereas the appearance
of*b8and*b9fragments implies that a dT2 is attached to a residue in the segment
264-IANKQFTA-271. Thus, at least one of the residues in the sequence 269-FTA-
271 must be a site of crosslinking. The intense signals produced by the singly
protonated (m/z 1119.6) and doubly protonated (m/z 560.4) forms of the free T28129
(Figure 4.6) suggest that the dinucleotide tag is easily lost from this nucleopeptide.
This might account for only two *b fragment ions that appear in the spectrum. The129
ion signals at m/z 1245.7 and m/z 623.4 correspond respectively to singly and
doubly protonatedT28129(1118.6 Da) crosslinked to thymine (126.1 Da). This is
additional evidence for the occurrence of "zero-length" photocrosslinking reactions
between the nucleic acid base thymine and amino acids.
In some instances a combination of exhaustive proteolytic digestion and MALDI-
TOF can provide information about the sites of crosslinked amino acids in
nucleopeptides [8]. The enzyme is used to remove non-crosslinked residues from
the N-terminal (aminopeptidase M) or from the C-terminal (carboxypeptidase) end
of the nucleopeptide. Since the proteolysis stops when the enzyme encounters a
crosslinked amino acid, the result is a truncated nucleopeptides whose molecular
weight can be determined by MALDI-TOF. This approach was attempted with
carboxypeptidase Y (CPY) in this study because carboxypeptidases have been
successfully used in combination with MALDI-TOF for C-terminal sequencing
[108-110] and CPY, in particular, cleaves nonspecifically from the C-terminus all
residues, including proline. In using this method, one must be aware that the
kinetics of enzymatic release for different amino acids varies considerably [108]
and, furthermore, thatitisquite possible for steric interference from the
oligonucleotide to limit the extent of the carboxypeptidase digestion.
It was necessary to use IMAC to clean up the CPY digested nucleopeptide sample
(Figure 4.7) in order to achieve a MALDI mass accuracy of about 0.05% in the
mass range of 9,00012,000 Da. The separation principle of IMAC is based on
electronic interactions between phosphate groups and metal ions(Fe3in this case)130
immobilized (chelated) to a stationary phase. This technique was recently
employed for enrichment of phosphorylated peptides from crude peptide mixtures
[111], as well as for the isolation of nucleopeptides [10]. Instead of using the
packed column format, it was found preferable in this study to use metal chelate
(MC) ZipTips (Milipore) designed for low volume (1-5 pL) samples.
Table 4.1 displays all possible average molecular weights of truncated hRPA7O
nucleopeptides generated by a C-terminal cleavage.
T24125
nucleopeptide
Average
Mass
(Da)
128/29
nucleopeptide
Average
Mass
(Da)
T43
nucleopeptide
Average
Mass
(Da)
xdT30 10691 T28129xdT30 10184 T43xdT30 9802
ATAFNEQVDKFFP xdT30 10578IANKQFTAV xdT30 10056VSDFGG xdT30 9646
ATAFNEQVDKFF xdT30 10481L&NKQFTA x dT30 9957VSDFG xdT30 9589
ATAFNEQVDKF X (1130 10334IANKQFT x dT30 9886 VSDF x dT30 9532
ATAFNEQVDK xdT30 10187IANKQF xdT30 9785VSD xdT30 9385
ATAFNEQVD xdT30 10059IANKQ xdT30 9638VS xdT30 9270
ATAFNEQV x dT30 9944lANK xdT30 9510V xdT30 9183
ATAFNEQ xdT30 9845IAN xdT30 9382
ATAFNE x dT30 9717IA xdT30 9268
ATAFN xdT30 9588IxdT30 9197
ATAF xdT30 9474
ATA xdT30 9327
ATxdT30 9256
AxdT30 9155
Table 4.1. Protonated average molecular weights of all possible truncated
hRPA7O nucleopeptides generated by a C-terminal cleavage. The molecular
weights in bold letters correspond to MALDI signals observed in Figure 4.7.131
By comparing the masses in Table 4.1 with the masses determined experimentally
from the CPY-digest spectrum shown in Figure 4.7, it was determined that the
signal at m/z 9532 corresponds to the T43 derived nucleopeptide VSDF x dT30, the
signal at m/z 9886 matches the T28129 derived nucleopeptide IANKQFT x dT30, and
the signals at m/z 9717 and m/z 10334 Da conform respectively to the *T24/25
derived nucleopeptides ATAFNE x dT30 and ATAFNEQVDF x dT30. Although the
mass is too inaccurate to be conclusive, the signal observed at m/z 9950 Da could
have been produced either by IANKQFTA x dT30 or by ATAFNEQV x dT30. The
experimental evidence obtained from the CPY digestion suggests that crosslinking
occurred to at least one amino acid from the sequence 383-VSDF-386 located in
T43, to least one residue in the segment 269-FT-270 in T28129, and to at least one
amino acid in the N-terminus segment 235-ATAFNE-240 of *T24/25
Using the data obtained from the carboxypeptidase digestion in conjunction with
the tandem mass spectral data it is possible to deduce a map of the DNA binding
domain of hRPA7O. These data are in good agreement with previous information
obtained from X-ray crystallography[56,99]and site-directed mutagenesis
[98,100].Each of thecrosslinkedpeptidesfrom hRPA7O containsone
phenylalanine residue previously identified as being involved in base stacking
interactions: F238 belongs to *T(235-ATAFNEQVDKFFPL-248), F269 is
located within T28129 (264-IANKQFTAVK-273) and F386 is from T43 (383-
VSDFGGR-389). According to the crystallography data [56], W361 has a weak
base stacking interaction in comparison with the phenylalanine residues (F238,132
F269 and F386); hence, it is not surprising that no mass spectrometric evidence was
found for the involvement of W361 in crosslinking.
Figure 4.8 shows the three-dimensional structure of an hRPA7O fragment (residues
183-420) obtained from crystallography data 56,99].
Figure 4.8. 3D structure of an hRPA7O fragment (residues 183-420) containing
the major DNA-binding region of the protein obtained from crystallography
data (56,99J. Several amino acids located in the DNA-binding channel of the
protein were identified by UV-photocrosslinking and mass spectrometry as being
crosslinked to oligonucleotide dT30. Each of the three distinct peptide regions
colored in blue have at least one crosslinked amino acid and these peptides are
located in the DNA-binding subdomain A (F269/T270 and 235-ATAFNE-240) or
in subdomain B (383-VSDF-386). All aromatic amino acids contained in these
peptides are colored in red. The drawing was generated using the RasMol program
[86].133
In this picture, helices are represented as spirals and 13 sheets are represented as
ribbons with arrows pointing in the C-terminal direction. All information obtained
to date by UV-photocrosslinking and mass spectrometry is summarized in this
figure.
Three distinct peptide regions colored in blue contain at least one crosslinked
amino acid. These peptides are located in the DNA-binding subdomain A
(F269/T270 and 235-ATAFNE-240) or in subdomain B (383-VSDF-386). There is
no evidence that a third binding domain (C) of hRPA is essential for binding DNA.
All aromatic amino acids contained in these peptides are colored in red. They can
form base stacking interactions with the DNA and, in the authors' opinion, are the
residues most likely to be involved in crosslinking. At this point, one can only
speculate that these aromatic amino acids are required for the formation of a stable
protein-DNA complex. More experiments will be required to confirm this
speculation and to show whether other amino acids are involved in crosslinking.134
5. SUMMARY AND CONCLUSIONS
The use of mass spectrometry for structurally characterizing nucleopeptide
complexes produced from UV-catalyzed crosslinking reactions is increasing [10].
As with mass spectrometric analysis, the key to success in this application lies
more in the preparation of the samples than in the operation of the instrumentation.
In this respect, the dual chemical nature of the nucleopeptides makes it particularly
difficult to prepare them for MALDI MS and LC/ESI MS.
One of the goals of the work presented in this thesis was test the general
applicability of a previously developed nucleopeptide purification protocol [11,12].
This procedure, developed initially for the {Ung (E. coli uracil DNA glycosylase)
dT20 system}, has been successfully applied in the present study to the isolation of
nucleopeptides from the UV-catalyzed crosslinking reaction of hRPA and dT30,
thus illustrating the procedure's robustness. In the case of {UngIdT2o } system, five
peptides corresponding to Ung T18, T11, and three truncated formsofT6(minus the
last three, five, and seven C-terminal amino acids) were identified as being
crosslinked to dT20 [11,12]. In the case of the {hRPA7O/dT30} system, three
peptides corresponding to hRPA7O T43, T28129, and one truncated form of T24125
(minus the last five C-terminal aminoacids) have been shown to crosslink to dT30.
Comparison of the hRPA-results presented in this thesis with those obtained in the
earlier Ung-studies reveals at least three characteristics that may be general to the135
purification and mass analysis of nucleopeptides. First, the tryptic peptide part ofa
nucleopeptide can undergo partial hydrolysis from the C-terminus during the
isolation procedure.Since thishydrolysis has not been observed forall
nucleopeptides in an isolated pool, it may be specific to a particular nucleopeptide's
amino acid sequence in relation to the location of the crosslinked amino acid
residue. Tentative identification of an individual peptide from its signal in the
MALDI spectrum relies heavily on knowing the specific pattern of cleavage that
produces the peptide during proteolysis. Since the peptide component ofa partially
hydrolyzed nucleopeptide is not tryptic as would be expected from the history of its
preparation, it is nearly impossible to recognize it from its signal in a MALDI mass
spectrum.
The accuracy of the MALDI measurement is usually not good enough by itself to
identify a segment in a protein'ssequence without knowing something about the
proteolytic process that produced it. Therefore, tandem MS experiments become
necessary to establish the identity of any nucleopeptides that hydrolyze during
sample preparation.Second, nuclease P1digestion of theoligonucleotide
component of a nucleopeptides has never been extensive enough to result in a
peptide crosslinked to a single nucleotide. In thecases of both Ung and hRPA7O,
P1 digestion was never observed to proceed beyonda dinucleotide. Third, the ESI
MS/MS spectra of the nuclease digested nucleopeptides produce,as might be well
expected, very complex spectra. In mostcases, but not all, CID induced
fragmentation of the oligonucleotide partoccurs more readily than fragmentation of136
the peptide part. Before tandem mass analysis of nucleopeptides becomes simple
and routine, methods must be found that enhance fragmentation of the peptide part
at the expense of the fragmentation of the oligonucleotide part.
Mass spectrometric analysis of nucleoprotein complexes seems to be primarily
limited by the amount of crosslinked product that is required prior to starting the
purification.In isolating nucleopeptides from the crosslinking of E. coli Ung to
dT20[11,12], over 1 nmol of crosslinked product was required to subsequently
isolate nucleopeptides for mass spectrometric analysis.In the present work with
the hRPA, approximately 800 pmol of crosslinked material was needed prior to
starting the nucleopeptide purification. The requirement for these large amounts of
starting material is a result of four factors: i) the number of steps in the purification
procedure, ii) the distribution of nucleopeptide product amongst a number of
peptides,iii) the hydrolytic loss of portions of the nucleopeptide's peptidic
component during purification, iv) the cleavage of the nucleopeptide into free
peptide and free oligonucleotide during purification. Aside from factor ii), which is
dependent on the biological interactions of the protein-DNA system under study,
efforts to minimize these factors must be made to reduce the amount of starting
material needed for mass spectrometric characterization. An example ofa move
toward this goal is a recent introduction of a microscale method for the analysis of
crosslinked nucleoprotein complexes [10].
The ultimate outcome of using a mass spectrometric analysis ofa peptide-nucleic
acid complex is the identities of specific amino acids thatare crosslinked to137
oligonucleotide. The rationale for seeking such data is that it can provide insight
into the mechanism by which the protein interacts with its nucleic acid substrate.
To date, tandem mass spectrometry has been successfully used to identify specific
aminoacids in Ung xdT20and liRPA x dT30 protein-DNA complexes that
crosslinked to the DNA strand. The fact that the crosslinked residues discovered by
mass spectrometry are several of the same amino acids that have been indicated by
X-ray crystallography to play key roles in the biological function of Ung and hRPA
suggests that it may not be too long before it will be possible to use mass
spectrometry to learn something about the biology of protein-nucleic acid
interactions.
The research objective of this thesis was to identify specific amino acids from Ung
and hRPA that are involved in binding DNA, to characterize the DNA-binding
domains of these proteins. Following a protocol developed in our laboratory, three
amino acids were identified from a short peptide region from Ung (H187, S189 and
H194) that are involved in binding to thedT20oligonucleotide. Using the same
protocol, three aromatic amino acids (F238, F269 and F386) from hRPA7O that
photocrosslink to dT30 were putatively identified. These results illustrate that
photochemical crosslinking and mass spectrometry can be successfully employed
in thestudy of non-covalent nucleoprotein complexes.Inaddition,these
experimental results demonstrate that mass spectrometry is an extremely versatile
and powerful tool in biology.138
I believe that my work will contribute to the overall understanding of the protein-
DNA interactions and I hope that more new applications of mass spectrometry in
this field will be seen in the future.IJ
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